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“The beginning of knowledge is the discovery of something we do not understand.”  








Development is both spatially and temporally a sensitive process. Nature has 
orchestrated growth in a very sophisticated manner, wherein the location of cells 
determines their fate. One response gives rise to another response, and it all must occur in 
the correct order at the correct time for development to occur properly. Behind all of 
these elaborate cell signaling processes lie individual cells, and within each exist thriving 
metabolic pathways that provide each cell with exactly what it needs to adapt and 
respond to cellular signals from its neighbors. 
The story of any developmental process should be told from the beginning, 
wherein two cells become one. The haploid egg and haploid sperm come together to form 
a fully functional diploid zygote, which divides repeatedly until it forms the blastocyst, 
which encompasses 256 identical cells. It is at this crucial point that cells run out of the 
resources to continue dividing as they have previously, and they begin to differentiate 
into three different cell types: endoderm, mesoderm, and ectoderm populations. These 
three layers begin to expand laterally until they form what is known as the neural plate, 
which hinges and grows until it fuses into a closed neural tube. This process is what my 
research focuses on, as this folding and fusion process is invariably important; it is the 
neural tube that eventually becomes the brain and spinal cord—both of which an 
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Mammalian folate-dependent one-carbon (1C) metabolism provides the building 
blocks essential during development via amino acid interconversion, universal methyl-
donor production, regeneration of redox factors, and de novo purine and thymidylate 
synthesis. Folate supplementation prevents most neural tube defects (NTDs) that occur 
during the embryonic process of neurulation. The mechanism of how folate functions 
during neurulation is not well understood, and not all NTDs are preventable by folate 
supplementation. Mthfd1l is a mitochondrial 1C metabolism enzyme that produces 
formate, a 1C donor that fuels biosynthesis and the methyl cycle in the cytoplasm. 
Mthfdll-null (Mthfd1lz/z) mice are embryonic lethal and develop folate-resistant NTDs. 
These mice also have defects in cranial mesenchyme formation. In this work, the nature 
of how their mesenchyme is defective is explored. The extracellular matrix (ECM) of 
Mthfd1lz/z embryos was found to be depleted in glycosaminoglycan (GAG) composition, 
as well as the basement membrane protein Collagen IV. Imaging mass spectrometry 
(IMS) was used to construct ion maps of the cranial mesenchyme that identified the 
spatial distribution and abundance of metabolites in Mthfd1lz/z embryos compared to 






diminished in the cranial mesenchyme of Mthfd1lz/z embryos. Loss of Mthfd1l activity in 
this region also led to abnormal levels of methionine and dysregulated energy 
metabolism. These alterations in metabolism suggest possible approaches to preventing 
NTDs in humans. Finally, we created a mouse lacking both Mthfd1l and Aldh1l2, which 
is another mitochondrial enzyme associated with formate production. These embryos 
exhibit a more dramatic birth defect phenotype than Mthfd1lz/z embryos. By associating 
metabolite abundance, gene expression, and tissue development, this study is focused on 
enhancing our current understanding of how folate-dependent 1C metabolism functions 
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CHAPTER 1: INTRODUCTION 
1.1 MAMMALIAN NEURAL TUBE CLOSURE 
1.1.1 Neurulation  
The developing mammalian embryo rapidly undergoes changes while it grows to 
become an autonomous organism. During the most crucial step of embryogenesis, 
ectoderm cells have expanded to form a wide neural plate, and must now bend and fuse 
to create a closed neural tube. This process is called neurulation, and it forms the basis of 
what ultimately becomes the central nervous system (CNS) of the developing embryo.  
This morphogenetic process is highly demanding of cellular resources, making 
biosynthesis a key requirement of neurulation. In turn, the metabolic processes that 
underlie these dynamic, early steps of development are crucial in driving embryogenesis, 
and will be reviewed in depth in the Chapter 1.2.  
 Neurulation begins during gastrulation, the process when dorsal midline ectoderm 
is induced to become neuroepilthelium, forming the neural plate (Copp, 2005) (refer to 
Figure 1). First, this layer of specialized ectoderm bends acutely at the midline, forming 
the median hinge point (MHP) immediately above the notochord, which creates the 
cross-sectional V-shaped ‘neural groove’ between two neural folds (McShane et al., 
2015). Simultaneously, the neural plate continues to elongate rostrocaudually by rapid 
cell division and convergent extension. During a second phase, the neural folds each bend 
at paired dorsolateral hingepoints (DLHPs) to form longitudinal furrows, resulting in a 
neural plate with a diamond shaped lumen. At this point, the tips of the neural plate are 
turned inward, and they continue to draw towards the dorsal midline as the entire 






forms a fused neural tube with a circular-shaped lumen. In experimental explants in cell 
culture, it was observed that the final stage of neural tube closure is dependent primarily 
on forces generated intrinsic to the neuroepithelium, unlike earlier stages in neural tube 
closure that are driven by forces extrinsic to the neuroepithelium (van Straaten et al., 
1993). Most substantial of the intrinsic forces that ultimately close the neural tube is cell 
proliferation, and areas of differing cell density result on either side of the DLHPs—a cell 
density difference that is proposed to cause the bending and fusion of the neural folds 
(Juriloff and Harris, 2018). Additional intrinsic mechanisms that are active during the 

















Figure 1.1: Morphological changes of neural plates to form the neural tube. “After 
neural induction (a), the neural plate bends at MHP (b) and is elevated to form the 
neural fold (c). Subsequently, flipping of the edges (asterisks) and bending at 
DLHP occur (d), resulting in apposition and fusion of the edges (e). Remodeling 
takes place to separate neuroectoderm and surface ectoderm (f). Neuroectoderm 
(neuroepithelum): pink. Non-neural ectoderm (surface ectoderm): green. 
Boundary region within non-neural ectoderm: orange. Notochord: yellow.” 













1.1.2 Neural Tube Defects 
The tightly regulated process of neurulation is complete by embryonic (or post-
conception) day 28 in the human, and day 10 in the mouse. This means that by the time 
most women discover they are pregnant, the neural tube has already closed—or not, in 
some cases. To allow the neural tube to close completely, a number of genes must 
cooperate in order for the following developmental mechanisms to take place: 
programmed cell death, neural crest cell migration, proliferation of neuroepithelium, 
contraction of apical cytoskeletal microfilaments, and flexing at DLHPs (Blom et al., 
2006). If these morphogenetic processes do not occur at precisely the correct moment, the 
neural tube does not close completely and the embryo will have a neural tube defect 
(NTD). Although closure of the neural tube is not required for subsequent specialized 
differentiation of neurons nor the formation of neuronal networks, it is essential for brain 
development (Copp, 2005). Many NTDs are lethal, including anencephaly, or failure of 
NTC in the cranial region, and craniorachischisis, or failure of NTC along the entire body 
axis. More common is failure to close at the caudal region of the neural tube, referred to 
as spina bifida or meningomyelocele; this NTD is associated with defects in the neural 
arches and is compatible with post-natal survival, although surgery is generally necessary 
and still results in significant neurological impairment (Wallingford et al., 2013). 
Exposure to the amniotic fluid is toxic for cells usually contained within the closed neural 
tube, and leads to neurodegeneration of the exposed regions in utero (Copp et al., 2013).  
The prevalence of NTDs differs across time and geography, but recent analysis 
concludes that they range from 3.3 to 27.9 per 10,000 births in the Americas alone, with 
increased instances in poorer countries with malnutrition and lack of preventative 
healthcare (Zaganjor et al., 2016). The lifetime medical expenses of a patient with spina 






physical and mental handicaps—the total cost of children born with spina bifida is over 
US$81 million annually in California (Blom et al., 2006). 
The complexity of the etiology of NTDs is further complicated by the influence of 
both environmental and genetic risk factors. Environmentally, maternal nutrition has been 
shown to play a significant role in NTD epidemiology; of particular importance is a diet 
rich in folate, a link that has been established since the 1960s (Hibbard and Smithells, 
1965). 
1.1.3 Folate Supplementation 
1.1.3.1 Folate and NTDs 
Between the years 1961 and 1963 at the Mill Road Maternity Hospital in 
Liverpool, Dr. Elizabeth Hibbard, MD assessed the folate levels of bone marrow, serum, 
and tissue of 1,484 patients, and found that folate-deficient mothers were more likely to 
have spontaneous abortions or fetal malformations (Hibbard, 1964). He concluded his 
report advising mothers to seek early prophylactic supplementation with folate in order to 
avoid birth complications. These findings were further explored the following year by Dr. 
Richard Smithells, wherein it was documented that a familial occurrence of birth defects 
suggested they were due to a “genetically determined defect of folate metabolism” 
(Hibbard and Smithells, 1965). It was not until 1991 that a randomized double-blind 
study was conducted at 33 different birthing centers in seven different countries, testing 
the efficacy of folate versus a cocktail of seven other vitamins (A, D, B1, B2, B6, C, and 
nicotinamide) in preventing birth defects (MRC Vitamin Study Research Group, 1991). 
This study revealed that a daily dose of 4mg folate was able to prevent up to 72% of 
NTDs in high risk mothers, whereas the other vitamins showed no such protective effect. 






of 400 µg folic acid  on a larger study population in China between 1993 and 1995, at 
which point NTDs were occurring at a high rate of 6 per 1000 births  (Berry et al., 1999).  
1.1.3.2 Mandatory Fortification 
The success of folate supplementation in preventing NTDs compelled the CDC to 
recommend that all women of childbearing age consume 400µg/day of folic acid (Centers 
for Disease Control and Prevention, 1992). However, by 1998, it was found that only 
29% of women consumed the recommended amount of folic acid; that same year, the 
United States made it compulsory to fortify all flour and enriched grain products with 
140µg folic acid/100 g (Centers for Disease Control and Prevention, 1999). Fortification 
was deemed more effective than vitamin supplementation at increasing the folate levels 
of both serum and red blood cells of women of childbearing age. The rate of NTDs 
decreased significantly in the years following fortification; depending on the region, the 
instance of NTDs was lowered by 31 to 78 % (Eichholzer et al., 2006). Fortification is 
currently mandatory in 70 countries, including the US, Canada, and Australia, yet it has 
still not been introduced in the European Union, despite evidence that it is effective at 
preventing NTDs (Bestwick et al., 2014). The fact that folic acid supplementation has not 
been successful at preventing 100% of NTDs indicates that some are folate-resistant. An 
assessment of the instance of NTDs among pregnancies conceived following mandatory 
fortification showed that there was no significant association of folic acid 
supplementation and NTDs (Mosley et al., 2009). These findings suggest that mandatory 
fortification may have ameliorated the instance of folate-sensitive NTDs. The mechanism 
of how folate is related to birth defects is not well-understood, and motivates further 




















1.2 FOLATE-DEPENDENT ONE-CARBON METABOLISM  
1.2.1 Folate in Mammalian cells  
From four tons of spinach, Esmond Snell and his colleagues first isolated folic 
acid in 1941 in Welch Hall at the University of Texas at Austin (Mitchell et al., 1941). 
The name “folic acid” was derived from the Latin term for leaves—folium. This vitamin 
was shown to serve as a growth factor for Streptococcus lactis, Lactobacillus casei, and 
Lactobacillus delbrückii, and a number of sources from animal liver to mushrooms were 
shown to be rich sources of this material. The report also concluded that commercially 
canned greens were “nearly lacking in the substance.” 
Folic acid and its reduced derivatives form the collective group of coenzymes 
known as folates, which can carry one-carbon (1C) units at different oxidation states. 
Folates contain a pteridine ring that is covalently linked at carbon 6 to a para-
aminobenzoic acid (PABA) with a poly-γ-glutamate tail (Figure 1.2). Activated carbon 
species are carried on N5 of the pteridine ring, or at N10, or both. In mammalian cells, 
tetrahydrofolate (THF) is biologically active form of folate. Dietary folic acid enters the 
cell via folate receptors (Folr), the reduced folate carrier (RFC), and the proton-coupled 
folate transporter (PCFT) (Radziejewska and Chmurzynska, 2019), and then it is reduced 
twice by the enzyme dihydrofolate reductase (DHFR) to THF, at which point it can begin 
to transfer 1C units. THF acts as a coenzyme in a wide range of different cellular 
reactions, as it gives cells the ability to readily interconvert 1C units between different 
oxidation states. The 1C-transfers mediated by THF are essential for a number of cellular 
processes: vitamin metabolism, nucleic acid biosynthesis, amino acid metabolism, methyl 






In cellular forms of folate, the PABA moiety is modified by a poly-γ-glutamic tail 
(Figure 1.2) in a reaction catalyzed by folylpolyglutamate synthetase (FPGS), and the 
length of this chain varies from one cell type to another; however, most common in 
eukaryotic cells are the penta- and hexaglutamate forms (Fox and Stover, 2008; Tibbetts 
and Appling, 2010). This modification serves to retain folate within a cell, and also 
makes it a more efficient substrate when interacting with folate-dependent enzymes 
(McBurney and Whitmore, 1974; Shane, 1989; Strong and Schirch, 1989). The 
interaction of folate cofactors and folate-binding enzymes is further promoted by an 
excess concentration of enzymes compared to their cofactor targets, which keeps cellular 











Figure 1.3: The structure of tetrahydrofolate (THF), a water soluble B vitamin with 
three distinct moieties: a fully reduced pterin ring, a para-aminobenzoyl group, 
and a poly-γ-glutamate tail. Activated 1C-units are carried on N5 and N10 (R1 and 
R2, respectively)  yield 5-methyl-, 5-formyl-, 5,10-methylene-, 5,10-methenyl, and 













1.2.2 Compartmentalization of Folate-mediated One-carbon Metabolism 
1.2.2.1 Overview of One-carbon Metabolism 
Tracing of [3H]-folic acid in rat liver demonstrated that folic acid is present 
throughout the cell; it is found in the cytoplasm, mitochondria, nucleus, lysosome, and 
microsomes (Yoon Soon Shin et al., 1976). It is most abundant in the cytosol and 
mitochondria (Lin et al., 1993), which are active sites of biosynthesis generated by the 
folate-mediated one-carbon metabolism. Once DHFR converts folate from the diet first 
into 7,8-dihydrofolate and then 5,6,7,8-tetrahydrofolate (herein referred to as THF), 
folate is biologically active and can participate in 1C-transfer reactions. In most 
organisms, the primary source of 1C units transferred to THF is carbon 3 of serine, in a 
reaction catalyzed by serine hydroxymethyltransferase (SHMT), which generates glycine 
and 5,10-methyl tetrahydrofolate (Fox and Stover, 2008; Tibbetts and Appling, 2010). 
Pools of THF are generally maintained in cellular compartments, most significantly the 
mitochondria, cytoplasm, and nucleus, wherein the extent of polyglutamylation varies by 
compartment with mostly heptaglutamates residing in the mitochondria and 
hexaglutamates predominating in the cytosol (Lin et al., 1993). These compartments 
remain connected by the transfer of the 1C-donors formate, serine, glycine, and less 
commonly sarcosine and dimethylglycine (Barlowe and Appling, 1988). The flux of 1C-
units across mitochondrial membranes assumes a mostly unidirectional flow in the 
clockwise direction (Figure 1.4) under most conditions. The main thrust of the pathway 
from the cytoplasm into the mitochondria and back into the cytoplasm is catalyzed by 
enzymes of the methylene-tetrahydrofolate (MTHFD) gene family. Mitochondrial 






unit bound to THF, whereas the cytoplasmic MTHFD1 catalyzes the three same reactions 
in the reductive direction. 
 
 
Figure 1.4: Compartmentalization of 1C-metabolism in mammalian cells between 
the mitochondria, cytoplasm, and the nucleus. Reactions of the pathway are 
catalyzed by the following enzymes:  SHMT2 (4m), MTHFD2/2L (3m and 4m), 
MTHFD1L (1m), MTHFD1 (1, 2, and 3), SHMT1 (4, 4n), GCS (5), MTHFR (6), 
MTR (7), DMGDH (8), SDH (9), thymidylate synthase (10, 10n, and 10m), 10-
CHO-THF dehydrogenase (ALDH1L2) (11), methionyl-tRNA formyltransferase 
(12), dihydrofolate (DHF) reductase (13), betaine-homocysteine 












1.2.2.2 Mitochondrial One-carbon Metabolism 
Approximately 40% of intercellular folate is found in the mitochondria (Yoon 
Soon Shin et al., 1976), and although it is not in a state of equilibrium with THF pools in 
the cytoplasm or nucleus (Lin et al., 1993), it is able to cross the mitochondrial membrane 
via SLC25A32, a transporter critical for survival in mice (Kim et al., 2018). Early tracing 
experiments using radiolabeled folic acid in rat liver demonstrated that THF rapidly 
accumulates in the mitochondria (Cook and Blair, 1979; Zamierowski and Wagner, 
1977), a finding that was corroborated much later when SLC25A32 was established as 
the mitochondrial folate carrier (Titus and Moran, 2000). Within the mitochondria of rat 
hepatocytes, the predominant forms of folate are THF and 10-formyl-THF. Among the 
remaining folate species, 11% is in the form of 5-formyl-THF, and less then 7% assumes 
the form of 5-methyl-THF (Horne et al., 1989). 
The net reaction of mitochondrial folate-metabolism is the oxidation of the 3-
carbon of serine or the N-methyl carbon of sarcosine to formate and CO2. Isolated 
mitochondria from adult rat liver readily produce formate and CO2 without any additional 
cofactors, indicating that all enzymes and cofactors required are present within the 
mitochondria (Barlowe and Appling, 1988). Serine crosses the mitochondrial membrane 
via SFXN1, which was shown to be essential for purine and glycine synthesis in cells 
(Kory et al., 2018). Serine then transfers its third carbon onto THF, generating glycine 
and 5,10-methylene-THF (CH2-THF), in a reaction catalyzed by SHMT2 (Figure 1.4, 
reaction 4m). SHMT2 is expressed in ubiquitously in adult and embryonic tissues, and 
knockdown of SHMT2 causes 1C-units to flow in the reverse, counterclockwise direction 
in cell lines (Motokawa and Kikuchi, 1971; Ducker et al., 2016). SHMT2 is upregulated 
in cancer cells, which has driven the hypothesis that glycine is in high demand in rapidly 






important 1C donor to THF via the glycine cleavage system (GCS, Figure 1.4, reaction 
5), which releases the final carbon in the form of CO2. The GCS is composed of glycine 
decarboxylase (GLDC), aminomethyltransferase (AMT), the hydrogen transferring GCS-
H protein, and the P-subunit, which catalyzes the PLP-dependent decarboxylation of 
glycine. Deletion of GLDC or AMT in mice causes NTDs, presumably due to a limited 
supply of 1C-units from mitochondrial folate metabolism (Pai et al., 2015).  
At this point in the pathway, two additional 1C donors may enter the 
mitochondria: sarcosine and dimethylglycine (DMG), both of which are intermediates in 
choline oxidation. Choline is a major dietary source of methyl groups by synthesis of S-
adenosylmethionine (AdoMet) (Stead et al., 2006). Upon entry to the cell, choline is 
either immediately phosphorylated to phosphocholine, or irreversibly oxidized to betaine, 
which can also serve as a methyl donor to homocysteine in the formation of methionine 
via catalysis by the cytoplasmic betaine hydroxymethyltransferase (BHMT, Figure 1.4, 
reaction 14) (Zeisel and da Costa, 2009). The other product of the BHMT reaction is 
DMG, which forms CH2-THF in the dimethylglyine dehydrogenase reaction (DMGDH, 
Figure 1.4, reaction 8). Sarcosine is formed either in the DMGDH reaction, or by glycine 
N-methyltransferase activity in the cytoplasm, and it can serve as a 1C donor in the 
mitochondria to form CH2-THF by sarcosine dehydrogenase (SDH, Figure 1.4, reaction 
9) (Tibbetts and Appling, 2010). DMGDH catalyzes DMG to sarcosine (mono-
methylglycine) and CH2-THF. SDH generates glycine, and in the presence of THF, CH2-
THF as well, as noted above, but in the absence of THF, the 1C unit is released as 
formaldehyde (Wittwer and Wagner, 1980). The formaldehyde can be oxidized by 
mitochondrial aldehyde dehydrogenase (ALDH2) to yield an alternate source of formate 






primary mode of formate production, with sarcosine and dimethylglycine serving as 1C 
donors instead of serine (Morrow et al., 2015). 
The next two reactions are catalyzed by bifunctional MTHFD2 or MTHFD2L, 
wherein CH2-THF is oxidized first to 5,10-methenyl-THF (CH+-THF) and then 
hydrolyzed to 10-formyl-THF (10-CHO-THF) (Figure 1.4, reactions 3m and 2m, 
respectively). Both enzymes exhibit dehydrogenase and cyclohyrolase activity. The 
redundancy of MTHFD2 and 2L in the mitochondria is currently not well understood. 
MTHFD2 is expressed in developing tissues and transformed cells in culture, but not 
adult tissues, whereas MTHFD2L is expressed in both embryonic and adult tissues (Di 
Pietro et al., 2004; Bolusani et al., 2011). MTHFD2-null mice are embryonically lethal, 
likely due to a defect in hematopoiesis caused by aberrant mitochondrial folate 
metabolism (Di Pietro et al., 2002). MTHFD2 has been of interest as a chemotherapeutic 
target, as tumors show a dramatic increase in MTHFD2 mRNA expression levels 
(Nilsson et al., 2014). Both MTHFD2 and 2L require NAD+ or NADP+ as a cofactor. 
Our lab has shown that both enzymes possess dual redox cofactor-specificity, although it 
was formerly thought that MTHFD2 was strictly NAD+-dependent (Shin et al., 2014, 
2017; Mejia and MacKenzie, 1985). 
The three fates assumed by the 1C unit of 10-CHO-THF in the mitochondria at 
this point are to be released as formate, (Figure 1.4, reaction 1m), be oxidized to CO2 
(Figure 1.4, reaction 11), or provide the formyl group for the initiation of mitochondrial 
protein synthesis (Figure 1.4, reaction 12).  In all three cases, free THF is returned to the 
mitochondrial pool. In the conversion of 10-CHO-THF to formate, the 10-CHO-THF 
synthetase protein MTHFD1L produces ATP from ADP and Pi, and returns THF to the 
mitochondrial folate pool (Figure 1.4, reaction 1m); once formate is produced, it rapidly 






1993). MTHFD1L is expressed in both adult and embryonic tissue (Pike et al., 2010; 
Prasannan et al., 2003), and in mice, embryos without MTHFD1L expression exhibit 
neural tube and orofacial defects with 100% penetrance (Momb et al., 2013). In humans, 
a common deletion/insertion polymorphism exists in MTHFD1L that affects splicing 
efficiency and also causes an increased NTD risk (Minguzzi et al., 2014; Parle-
McDermott et al., 2009). In cancer cells, MTHFD1L expression was found to be 
upregulated, indicating that cancer cells may require mitochondrial formate for 
proliferation (Selcuklu et al., 2012). MTHFD1L will be further characterized in Chapter 
1.3. 
Mitochondrial 10-CHO-THF dehydrogenase, encoded by the ALDH1L2 gene, 
catalyzes the oxidation of 10-CHO-THF to CO2 and THF in a NADP+ dependent reaction 
(Figure 1.4, reaction 11). ALDH1L2 is expressed in mitochondria of liver (Barlowe and 
Appling, 1988), retina, and brain in the rat (Neymeyer and Tephly, 1994). The production 
of CO2 is increased in uncoupled mitochondria, and depends on NADP+ and THF in 
soluble extracts (García-Martínez and Appling, 1993). Additionally, it has been proposed 
that 1C metabolism plays a role in redox metabolism by contributing to NADPH 
production via ALDH1L2 activity, based on work done in cancer cell lines (Ducker et al., 
2016; Tedeschi et al., 2013). ALDH1L2 will be further characterized in Chapter 1.4. 
The final pathway taken by 10-CHO-THF is to formylate the initiator tRNA, Met-
tRNAMet, which has been observed in bacterial, yeast, chloroplast, and mitochondrial 
systems (Figure 1.4, reaction 12) (Halbreich and Rabinowitz, 1971; Kozak, 1983). 
Metazoan mitochondria, unlike bacterial systems, express a single tRNAMet that fulfills 
the roles of both initiation and elongation, thereby those designated for initiation 
purposes are formylated by 10-CHO-THF via methionyl-tRNA formyltransferase 






been shown to have a high affinity for fMet-tRNAiMet, which initiates protein translation 
at the P site of the mitochondria (Spencer and Spremulli, 2004).  
Although formylation of Met- tRNAMet has been shown to be nonessential in 
some systems (Newton et al., 1999; Li et al., 2000; Tibbetts et al., 2003), depletion of 
cellular formylation activity has also been shown to cause growth defects in E.coli 
(Guillon et al., 1992; Varshney and RajBhandary, 1992; Meinnel et al., 1993), and human 
mutations in MTFMT have been associated with the neurological disorder Leigh’s 
syndrome, as well as defective mitochondrial protein synthesis (Tucker et al., 2011). 
1.2.2.3 Cytoplasmic One-carbon Metabolism 
The distribution of folates in the cytosol differs from that of the mitochondria. In 
the cytoplasm of rat hepatocytes, 45% of THF was in the form of 5-methyl-THF, 30% 
was assumed by 10-formyl- and 5-formyl-THF, and 25% was found to be free THF 
(Horne et al., 1989). In the cytoplasm, the same oxidative reactions as in the 
mitochondria are present, but the cytoplasmic redox state favors a flow in the reductive 
direction (Figure 1.4, reactions 1-4).  These cytoplasmic interconversions of the 1C-unit 
bound to THF are coupled with several biosynthetic reactions that contribute to purine 
synthesis, thymidylate production, and AdoMet restoration in the methyl cycle. 
Metabolic tracer experiments in mouse embryonic fibroblasts have shown that at least 
75% of the 1C units that flow into the methyl cycle are mitochondrially derived (Pike et 
al., 2010). 
The flow of 1C units into the cytoplasm commences with formate released from 
the mitochondria, which reacts with free cytoplasmic THF to form 10-CHO-THF in a 
reaction catalyzed by the 10-CHO-THF synthetase activity of the trifunctional C1-THF-






in no net ATP production from the mitochondrial synthetase reaction. MTHFD1 is 
essential for life, as mice that do not express C1-THF-synthase are embryonically lethal; 
furthermore, heterozygosity has been associated with AdoMet deficiency, altered 
homocysteine metabolism, and a decrease in uracil misincorporation in nuclear DNA in 
the liver (MacFarlane et al., 2009). The embryonic lethality of these mice as well as the 
dysregulated folate metabolism of the heterozygotes emphasize the importance of 
mitochondrially-derived formate as a 1C donor in purine synthesis, which is explained 
further in this section.  
As in the mitochondria, 10-CHO-THF has several fates in the cytoplasm. One 
very significant destiny for 10-CHO-THF is to act as a substrate in de novo purine 
synthesis; 10-CHO-THF is used to formylate carbons 8 and 2 of the purine ring by 
glycinamide ribonucleotide (GAR) and 5-aminoimidazole-4-carboxamide ribonucleotide 
(AICAR) transformylases, respectively (Figure 1.4) (Wyngaarden, J.B. and Kelley, W.N., 
1983). The ten step enzymatic pathway of de novo purine biosynthesis is universal, and 
10-CHO-THF is essential as a cofactor for the key formylation steps (Barlowe and 
Appling, 1988; Pasternack et al., 1994; Warren et al., 1996). 
Alternately, cytoplasmic 10-CHO-THF dehydrogenase (ALDH1L1) oxidizes 10-
CHO-THF to CO2 and THF. With extremely high expression levels in adult liver, 
ALDH1L1 accounts for 1.2% of total cellular protein (Cook and Wagner, 1982). 
ALDH1L1 is downregulated in cancer tissue and has been shown to have suppressive 
effects on cancer cell growth (Krupenko and Oleinik, 2002), which is consistent with its 
impact of diminishing nucleotide biosynthesis. Conversely, it has been shown to be 
upregulated during CNS development (Anthony and Heintz, 2007), thereby suggesting 






Finally, 10-CHO-THF may be reduced to CH2-THF by the cyclohydrolase and 
dehydrogenase activities of MTHFD1 (Figure 1.4, reactions 2 and 3). CH2-THF can serve 
as a 1C donor for thymidylate synthesis (Figure 1.4, reaction 10) or serine synthesis 
(Figure 1.4, reaction 4). Thymidylate synthase (TYMS, Figure 1.4, reaction 10) forms 
thymidylate (dTMP) from the reductive methylation of deoxyuridylate (dUMP), through 
a unusual folate 1C transfer where THF is oxidized to DHF (Santi and Hardy, 1987). 
DHF is restored the active folate cycle by being reduced back to THF by DHFR. As 
proliferating cells require rapid DNA synthesis, requiring an ample supply of 
thymidylate, TYMS is a common chemotherapeutic target (Peters et al., 2002). 
Alternatively, CH2-THF can be reduced to 5-methyl-THF (CH3-THF) by 
methylenetetrahydrofolate reductase (MTHFR), irreversibly committing it into the 
methyl cycle (Figure 1.4, reaction 6). The most reduced 1C-folate unit, CH3-THF is 
abundant in the cytoplasm and is produced by MTHFR in a NADPH-dependent manner. 
Disruptions in MTHFR functioning—such as that which occurs in the common human 
C677T MTHFR polymorphism—have been associated with NTDs, Alzheimer’s disease, 
schizophrenia, cardiovascular disease, and autism, among others (Yang et al., 2015; El-
Hadidy et al., 2014; Román, 2015; Liew and Gupta, 2015; Rai, 2016; Sener et al., 2014). 
These issues are consistent with the critical need of a steady supply of 1C units to the 
methyl cycle in order to maintain healthy cellular function.  
Next in the methyl cycle, methionine synthase (MTR) consumes CH3-THF, in a 
cobalamin (vitamin B12)-dependent fashion, releasing THF into the cytoplasmic folate 
pool and forming methionine from homocysteine (Figure 1.4, reaction 7). Homocysteine 
remethylation is particularly important because methionine is adenylated by AdoMet 
synthetase to form the reactive methyl carrier AdoMet, which is the universal methyl 






Not only does it play an influential role in epigenetics, but AdoMet is considered the 
second most important cofactor after ATP, and functions in sulfur metabolism as well as 
the biosynthesis of creatine, polyamine, and phosphotidylcholine (Finkelstein, 1990; 
Mudd et al., 2007; Su et al., 2016). Methylation by AdoMet releases S-
adenosylhomocysteine (AdoHcy) as a byproduct; in adult mammals, the greatest source 
of SAH and thereby the largest 1C sink is phosphotidylcholine synthesis from 
phosphoethanolamine (Stead et al., 2006). SAH hydrolase catalyzes the breakdown of 
SAH into adenosine and homocysteine (Turner et al., 2000), the latter of which can either 
re-enter the methyl cycle, or synthesize cysteine via the transsulfuration pathway (Mudd 
et al., 1965).  
Finally, CH2-THF that does not enter the methyl cycle or produce thymidylate 
transfers its 1C unit to glycine in a reaction catalyzed by cytosolic SHMT1, forming 
serine and releasing THF back to the cytoplasm. SHMT1 has been shown to compete 
with MTHFR for CH2-THF, as AdoMet levels decrease when SHMT1 is overexpressed 
in mice (MacFarlane et al., 2011). Mice lacking SHMT1 are viable and fertile, indicating 
that  this enzyme does not produce essential 1C units; however, when fed a folate-
deficient diet, these mice experience an increase in NTDs compared to WT (MacFarlane 
et al., 2008). The viability of shmt1-null animals is likely due to the fact that the most 
serine synthesis occurs in the mitochondria (via SHMT2) rather than in the cytoplasm. 
Additionally, SHMT2 has been shown to produce two transcripts, one of which 
(SHMT2α) localizes to the nucleus and cytoplasm. SHMT2α is likely responsible for 
SHMT-dependent thymidylate synthesis that occurred in the absence of SHMT1 in 






1.2.2.4 Nuclear One-carbon Metabolism 
Within the nucleus, there exists a dTMP synthesis cycle catalyzed by TYMS, 
DHFR, and SHMT1 (Woeller et al., 2007). This cycle involves a unique folate 1C 
transfer, catalyzed by TYMS, wherein the THF carrier is oxidized to DHF in the transfer 
of electrons to the 1C unit—thereby reducing it to a methyl group, which is transferred to 
dUMP to form dTMP (Figure 1.4, reaction 10n). DHF is reduced back to THF and 
restored to its active state in the folate pool by DHFR (Figure 1.4, reaction 13). Serine 
serves as the 1C donor via SHMT1 (Figure 1.4, reaction 4n, Anderson and Stover, 2009), 
which confirms previous studies in MCF-7 cells that established SHMT1 as rate-limiting 
for dTMP synthesis (Herbig et al., 2002). During S and G2/M phases of the cell cycle, 
TYMS, DHFR, and SHMT1 are all modified with a small ubiquitin-like modifier 
(SUMO), which cues them to translocate into the nucleus (Anderson et al., 2007; Woeller 
et al., 2007). Impaired thymidylate synthesis in the nucleus has been associated with 
accumulation of uracil in the DNA of mice, indicating that nuclear thymidylate synthesis 
















1.3 MITOCHONDRIAL 10-FORMYL-THF SYNTHETASE: MTHFD1L 
1.3.1 Enzymatic Characterization  
In a healthy cellular environment, the majority of 1C units used in cytoplasmic 
reactions are derived from formate produced in the mitochondria, catalyzed by 
MTHFD1L (reviewed in Tibbetts and Appling, 2010). The MTHFD1L gene encodes 
mitochondrial 10-formyl-THF synthetase, hence we refer to this enzyme as MTHFD1L. 
Although it shares 61% sequence similarity (Figure 1.5) with its trifunctional cytoplasmic 
counterpart C1-THF synthetase (MTHFD1), MTHFD1L is monofunctional (Walkup and 
Appling, 2005). MTHFD1 and MTHFD1L both contain homologous C-terminal 
synthetase domains of approximately 70 kDa and homologous N-terminal 
dehydrogenase/cyclohydrolase domains of approximately 30 kDa, linked through a 
proteolytically sensitive connector region. Due to substitutions in the N-terminus of 
MTHFD1L, the dehydrogenase/cyclohydrolase domain is catalytically inactive 
(Christensen et al., 2005). 
Our lab enzymatically characterized MTHFD1L, and found it to exist as a 
homodimer in solution. We first identified MTHFD1L in 2003 in human uterine RNA, 
and it was found to span 236 kilobase pairs on chromosome 6, consisting of 28 exons 
plus one alternative exon (Prasannan et al., 2003). The gene encodes a protein of 978 
amino acids, and is expressed ubiquitously, with greatest abundance in placenta, spleen, 
thymus, and brain (Prasannan and Appling, 2009; Prasannan et al., 2003). Expression is 
observed ubiquitously at all stages of mammalian embryogenesis, with highest levels of 
localized expression in the brain, neural tube, craniofacial structures, limb buds, and tail 








Figure 1.5 Alignment of human and mouse mitochondrial MTHFD1L with human 
cytoplasmic MTHFD1. Black boxes denote identity, and white 
boxes denote conservative substitutions or identities in two of three proteins. 
The alignment was produced by the INRA server at the Laboratoire de 
Génétique Cellulaire (prodes.toulouse.inra.fr/multalin/multalin.html) using 
the MultAlin algorithm, and the output was generated by the ESPript 
program at the same site.  hmito, human mitochondrial MTHFD1L; mmito, 
mouse mitochondrial MTHFD1L; hcyto, human cytoplasmic MTHFD1 











1.3.2 Implications in human health 
Considering that mitochondrial formate is the 1C source for biosynthetic reactions 
of the cytoplasm, it is plausible that disruption in the production of this formate via 
MTHFD1L will have dramatic implications on cellular homeostasis. In separate 
microarray experiments, MTHFD1L was found to be upregulated in both breast and colon 
adenocarcinomas (Sugiura et al., 2004; Jain et al., 2012). Furthermore, an increase in 
MTHFD1L expression has been associated with metastasis of hepatocellular carcinomas 
in cancer patients (Lee et al., 2017). Beyond its associations with cancer, several 
polymorphisms in the human MTHFD1L gene have been independently associated with 
an increased risk of NTDs, coronary heart disease, and Alzheimer’s disease.  
Strongly correlated with increased NTD risk, the MTHFD1L deletion/insertion 
polymorphism rs3832406 involves a varying number of ATT repeats that influence 
splicing efficiency (Parle-McDermott et al., 2009). Because the intronic rs3832406 
occurs in close proximity to an alternatively spliced exon, it possibly results in a shorter 
transcript that lacks synthetase activity, as previously reported by Priya Prasannan in our 
lab (Prasannan et al., 2003). This polymorphism was observed in an Irish population. The 
link between Mthfd1l polymorphisms and NTD risk has been shown to be affected by 
differences in microRNA regulation (Minguzzi et al., 2014) 
In addition to NTDs, MTHFD1L has also been associated with coronary artery 
disease (CAD). In both British and German populations, the intronic SNP rs6922269A>G 
has been associated with cardiovascular mortality and CAD (Samani et al., 2007; 
Angelakopoulou et al., 2012; Franceschini et al., 2011; Hubacek et al., 2016; Morgan et 
al., 2011; Palmer et al., 2014; Saade et al., 2011). Because mitochondrial formate is the 
source of at least 75% of 1C units that enter the methyl cycle and produce methionine 






healthy level of homocysteine in the cell (Pike et al., 2010). Hyperhomocystemia has 
been shown to lead to endothelial cell damage, altered haemostasis, and a reduction in the 
flexibility of blood vessels (Ganguly and Alam, 2015), all of which reduce the quality of 
cardiovascular function. Folate supplementation has also been shown to significantly 
lower homocysteine concentration and reduce cardiovascular disease in patients (Ward, 
2001). 
Another polymorphism of MTHFD1L, rs11754661, has been implicated in 
neurological disorders—most predominantly, in Alzheimer’s disease, but also autism and 
schizophrenia (Naj et al., 2010). The association of this SNP with late-onset Alzheimer’s, 
a neurodegenerative disorder with cognitive impairment, was detected in Han Chinese 
populations, among others (Ren et al., 2011; Ma et al., 2012). As mentioned above, 
MTHFD1L plays an important role in preventing hyperhomocystemia; excessive 
homocysteine has been implicated as being neurotoxic by overactivating NMDA 
receptors that lead to a sustained phosphorylation of ERK-MAP kinase, causing 
uncontrolled cell death (Poddar and Paul, 2009). This hypothesis has been further 
supported in studies in humans and mice with elevated homocysteine levels and 
decreased MTHFD1L expression in the hippocampus (Naj et al., 2010; Hasegawa et al., 
2010). 
1.3.3 Mouse Models 
The Mthfd1l-null mouse model was first reported by Jessica Momb of our lab, 
with an embryonically lethal phenotype and 100% penetrance of NTDs (Momb et al., 
2013). Although all nulls have NTDs, these embryos exhibit variable phenotypes, 
including orofacial defects, craniorachiscisis, wavy neural tube, and exencephaly, with 






to folate supplementation, but the NTDs are partially rescued with sodium formate 
supplementation (Figure 1.7). The fact that folate does not prevent these birth defects 
from occurring indicates that the production of formate is essential for proper neural and 
orofacial development, thereby rendering the Mthfd1l-null mouse a model for folate-
resistant NTDs.  
Formate was also shown to prevent NTDs in a study that analyzed Mthfd1l 
expression in the curly-tail mouse (Sudiwala et al., 2016). The curly tail mouse, like 
Mthfd1l-null mice, is a folate-resistant NTD mouse model, with instances of both spina 
bifida and exencephaly. By an unknown mechanism, MTHFD1L expression is 














Figure 1.6 Neural tube defects and orofacial defects in Mthfd1lz/z embryos. 
“Compared with WT E12.5 embryos (A), E12.5 Mthfd1lz/z embryos (B-E) 
exhibit a spectrum of neural tube defects including exencephaly (B, red 
arrowhead). (C) Embryo with completely open neural folds 
(craniorachisisis) is indicated by the dashed lines. Note that the embryo 
curves to the left so the entire open neural tube is visible (red arrowheads). 
(D) Embryo with exencephaly (red arrowhead) and a wavy neural tube. (F) 
WT, 51-somite embryo showing normal facial development. (G) Same 
Mthfd1lz/z embryo (51 somites) imaged (D and E) displaying facial defects.” 













Figure 1.7 “Maternal supplementation with sodium formate improves development 
and growth in Mthfd1lz/z embryos. Pregnant dams were administered a 
calculated dose of 7,500 mg⋅kg−1⋅d−1 sodium formate. Mthfd1lz/z embryos 
dissected at E11.5 (B) Improved growth compared with control embryos 
from unsupplemented dams (A). E13.5 embryos from unsupplemented (C) 
and supplemented (D) dams. Precise age of embryos: (A) WT, 47 somites; 
z/z, 36 somites; (B) WT 45 somites; and z/z, 41 somites; (D) not determined 









1.4 MITOCHONDRIAL 10-FORMYL-THF DEHYDROGENASE: ALDH1L2  
 Exceptional in the folate 1C pathway are the 10-formyl-THF-dehydrogenases; 
whereas other enzymes utilize THF for biosynthetic processes, these enzymes are 
catabolic. A human gene with 74% similarity to the cytosolic 10-formyl-THF 
dehydrogenase (ALDH1L1) was found to be localized to the mitochondria, and thereby is 
referred to as ALDH1L2 (Krupenko et al., 2010). Mitochondrial 10-formyl-THF 
dehydrogenase was found to be a later evolutionary product, based on gene analysis 
across species. Both ALDH1L 1 and 2 catalyze the formation of CO2 and THF from 10-
formyl-THF in an NADP+ dependent manner, and they exemplify how folate metabolism 
has evolved to become functionally integrated into separate cellular compartments 
(Strickland et al., 2011a).  
Structurally, ALDH1L2 is nearly identical to ALDH1L1, as the main difference 
in sequence arises from the 22 amino acid mitochondrial localization signal. Both 
isozymes possess a C-terminal aldehyde dehydrogenase domain, homologous to aldehyde 
dehydrogenases (ALDHs), and an N-terminal hydrolase domain, which are connected by 
an intermediate domain (Figure 1.8) (Strickland et al., 2011b; Tibbetts and Appling, 
2010). The linker intermediate domain is both structurally and functionally homologous 
to acyl carrier proteins, and contains a site of attachment (Ser354) for a 4’-pentathione 
arm that swings to transfer the formyl group bound to the N-terminal domain over to the 
C-terminus (Donato et al., 2007; Krupenko, 2009). This mechanism is completed with the 
release of the formyl group as CO2 by the aldehyde dehydrogenase domain. However, in 
the presence of exogenous thiols, this enzyme produces formate instead of CO2 in vitro 
(Osborn et al., 1957; Min et al., 1988; Rios-Orlandi et al., 1986; Scrutton and Beis, 1979; 
Krupenko et al., 1995). The exogenous thiols in this reaction include 2-mercaptoethanol 






for formate production by ALDH1L2 in vivo. Because mitochondria are rich in 
glutathione (more than 10mM), it is possible that the hydrolase activity of ALDH1L2 is 
supported in this organelle (Shen et al., 2005; Strickland et al., 2011a). Also of note, both 
ALDH1L1 and ALDH1L2  catalyze the hydrolase reaction with a similar Km value, but 
the Vmax of the mitochondrial isoform was about 7 times higher than its cytoplasmic 
counterpart (Strickland et al., 2011a).  In Mthfd1l-null embryos, mitochondria continue to 
produce a low level of formate, and ALDH1L2 expression has been shown to increase 
(Bryant et al., 2018). Because mitochondrial formate production contributes so 
significantly to the biosynthetic cellular pool, these findings by Dr. Bryant suggest that 
ALDH1L2 may compensate for the lack of formate in the absence of MTHFD1L 
expression. In Chapter 4, I explore the metabolism of a mouse that does not express 
MTHFD1L or ALDH1L2 in an attempt to better comprehend the source of residual 
mitochondrially-produced formate in Mthfd1l-null embryos, and decipher if ALDH1L2 is 














Figure 1.8 Domain organization of mitochondrial and cytoplasmic 10-formyl-THF 
dehydrogenases and the reactions they catalyze. The N-terminal 
hydrolase domain consists of residues 1-310 and the C-terminal ALDH 
domain contains residues 420-902. The full length enzyme is required for 
reaction 1, and the hydrolase reaction can be catalyzed by the full length 

















 1.5 OBJECTIVE 
 Six years ago, our lab established that mice lacking Mthfd1l expression are born 
with defects in neural tube closure (Momb et al., 2013). The mechanistic link that 
explains this failure of the neural tube to close remains undescribed and not well 
understood, however. Furthermore, we lack a thorough analysis of the metabolic 
differences that exist between wild-type and Mthfd1l-null mice with respect to spatial 
distribution in the tissue. Although the compartmentalization of folic acid derivatives has 
been thoroughly analyzed on a cellular level (reviewed in Tibbetts and Appling, 2010), 
we have yet to quantify and compare the distribution of folate-associated metabolites on a 
larger, tissue-based level during development, when the presence of folate is necessary 
for proper growth and morphology. 
 In this dissertation, I will describe my studies dedicated to better understanding 
the mechanisms of neural tube closure (NTC). In Chapter 2, I focus on the composition 
of cranial tissue during NTC using histology and immunohistochemistry. I expand this 
understanding to the biochemical realm in Chapter 3 by applying imaging mass 
spectrometry in an attempt to describe the biochemical landscape during tissue 
development. In Chapter 4, I introduce a novel mouse model that lacks two folate one-
carbon pathway associated enzymes, Mthfd1l and Aldh1l2, both of which are associated 
with mitochondrial formate production. This double knockout mouse serves to 
demonstrate the importance of mitochondrially-derived formate in biosynthesis during 









CHAPTER 2: DELETION OF MTHFD1L IN MICE CAUSES 





MTHFD1L is responsible for mitochondrial formate production, which accounts 
for 75% of 1C units that enter the methyl cycle (Pike et al., 2010). The methyl cycle is 
responsible for the production of methionine, an indispensable metabolite in all 
eukaryotic translation, as it serves as the initiating codon. Methionine is also the source of 
all methyl groups in the cell, via its conversion to AdoMet. In addition to the methyl 
cycle, MTHFD1L provides cytoplasmic formate as a source of 1C units for other 
biosynthetic reactions as well, producing purines and thymidylate. MTHFD1L is 
expressed throughout the entire embryo during all stages of development, and shows 
increased expression in the neuroepithelium, along the length of the folding neural plates, 
and the underlying paraxial mesoderm (Figure 2.1, Shin et al., 2014). Mice without 
Mthfd1l do not survive beyond E12.5, and experience 100% penetrance of birth defects, 
including exencephaly and craniofacial defects (Figure 1.5). In turn, proper neural tube 
closure and healthy development, especially in the cranial region, requires MTHFD1L 
expression. This chapter will focus on the mechanisms involved in cranial neural tube 
closure. 
Recent experiments done by myself and colleague Dr. Minhye Shin have 
indicated that Mthfd1l-null mice display reduced density in the mesenchymal cells that 
underlie and expand the cranial neuroepithelium. A similar phenotype has been observed 






This study examined the effect of methionine adenosyl transferase inhibition on 
embryonic development, which caused both exencephaly and a decrease in cranial 
mesenchyme density. In our lab, Dr. Shin examined a number of cellular processes in 
order to understand how Mthfd1l deletion in our mouse model led to a decrease in 
mesenchyme density. Using immunohistochemistry and in situ hybridization methods, 
she analyzed neuroepithelial cell proliferation, apoptosis, and neural crest cell 
specification. Phosphohistone H3 was used as a marker of cellular mitotic index to 
examine if Mthfd1l deletion led to a decrease in cellular proliferation, however there was 
no difference between the Mthfd1l-null mice and WT mice until after neural tube closure 
(18-24 somites) (Shin, 2016). The reduced cellular proliferation at this later stage is 
consistent with other 1C metabolism gene knockout mouse models, wherein proliferation 
is reduced between E9 - E11.5 (Pai et al., 2015; Tang et al., 2005). This reduction in 
cellular proliferation may be in response to the lack of neural tube closure in the 
hindbrain which occurs in the Mthfd1l-null mouse model.  
Dr. Shin also examined apoptosis in this mesenchymal cell population using 
Caspase-3 as a marker, and observed no difference between the levels of apoptosis 
between WT and Mthfd1l-null mice. Because cranial mesenchyme is derived from both 
paraxial mesoderm and neural crest cells, it is also possible that the reduced cellular 
density was caused by a failure of neural crest cell migration to this region. The 
expression patterns of neural crest cell markers Sox9 and FoxD3 were examined using 
whole-mount in situ hybridization. Dr. Shin did not observe dramatic differences in 
staining of Sox9 or FoxD3 between somite-matched wild-type and Mthfd1l-null embryos, 







In this chapter, I further explore the cranial tissue morphology of the Mthfd1l-null 
mouse model, and the cellular and biochemical mechanisms at work during development 
of that morphology. Before delving into my work on this topic, I will review findings on 





Figure 2.1. Mthfd1l is expressed ubiquitously but most highly in the basal 
neuroepithelium. Whole-mount in-situ hybridization at E8.75 (A), E9.5 (B), and 
E10.5 (C) show abundant expression of Mthfd1l in the developing forebrain, the 
limb buds, and the branchial arches (arrows). Expression is observed in the 
folding neural plates at E8.75 (arrows in A). This hybridization experiment was 













2.1.2 Mesenchyme and Extracellular Matrix (ECM) in Morphogenesis 
In the nineteenth century, it was accepted as truth that both vertebrate and 
invertebrate embryos across all taxa develop identically. “Germ layer theory,” 
popularized by Aleksandr Kovalevsky and Ernst Haeckel, posited that the three 
gastrulation-derived germ layers (ecto-, meso-, and endo-derm) give rise to a universal, 
fixed set of organs (Haeckel, 1874). Brothers Oscar and Richard Hertwig, among other 
embryologists of the late 1800s, refuted this claim, and coined the phrase “mesenchyme” 
to describe a protoplasmic network, filled with a fluid intercellular substance, that may be 
derived from all three germ layers, but is primarily mesodermal in origin (Hertwig and 
Hertwig, 1881). They further described that mesenchyme gives rise to a variety of tissues 
depending on the organism, albeit most are connective in nature. This early view sheds 
light on the structural importance of mesenchyme, as well as the interconnectivity this 
tissue maintains with its extracellular matrix. 
Mesenchyme in the cranial region is derived from the anterior paraxial mesoderm 
and the neural crest. Both populations are required for neural fold elevation in rodent and 
chick embryos (Morriss-Kay, 1981; Fleming et al., 1997; Colas and Schoenwolf, 2001; 
Copp, 2005). Paraxial mesoderm, originating from the primitive streak, migrates to the 
anterior region of the embryo along the underside of the presumptive neural plate from 
early gastrulation (E6.5) to neural tube closure (E9.5) (Yoshida et al., 2008). 
Simultaneously, neural crest cells are induced at the junction of the neural plate and 
epidermal ectoderm, undergo epithelial to mesenchymal transition, and migrate into the 
frontonasal region, first branchial arch, and trigeminal ganglion (Noden and Trainor, 
2005). Mesenchyme from the paraxial mesoderm will ultimately form bones of the skull 
vault and muscles in the face; that from the neural crest eventually becomes cranial 






cranial neural crest cell formation or emigration have been associated with exencephaly 
in mice, although the mechanism for how failure to close the cranial neural tube is not 
well understood (Bamforth et al., 2001). 
 As the newly formed mesenchyme cells populate the cranial region, which occurs 
between 7-10 somite stages, the neural folds begin to elevate, transforming the neural 
plate into a “V” shape with a neural groove in the center (Zohn and Sarkar, 2012). This 
marks the first phase of cranial neurulation, and several KO mouse models (twist, Cart1, 
Ski, Alx3, Inka1) have demonstrated that cranial mesenchyme is essential to this phase 
(Berk et al., 1997; Chen and Behringer, 1995; Copp et al., 2003; Lakhwani et al., 2010; 
Reid et al., 2010; Zhao et al., 1996). During neural fold elevation, the amount of cranial 
mesenchyme cells increase, as well as the space between the cells, resulting in expansion 
of the tissue (Morriss and Solursh, 1978; Morris-Wiman and Brinkley, 1990a). Neither 
proliferation nor apoptosis explains this dramatic increase in mesenchyme expansion and 
neural fold elevation (Morris-Wiman and Brinkley, 1990b). Correlative data in rodents 
have indicated that expansion of the extracellular matrix (ECM) drives mesenchymal cell 
translocation and neural fold elevation (Morriss and Solursh, 1978; Morriss-Kay, 1981; 
Morris-Wiman and Brinkley, 1990a; Zohn and Sarkar, 2012).  
The ECM is composed of glycosaminoglycans (GAGs), proteoglycans (PGs), 
collagens, and non-collagenous glycoproteins. GAGs are linear, unbranched 
polysaccharides with a repeating disaccharide unit that contains hexosamine and uronic 
acid. These molecules are abundantly modified with carboxyl, sulfate, and hydroxyl 
groups, which give GAGs polyionic and electrostatic properties. In turn, they are 
osmotically active and attract Na2+ ions, which draws in water and causes the interstitial 
spaces surrounding GAGs to swell (Rozario and DeSimone, 2010). The swelling of this 






processes involved in morphogenesis (Toole, 1997). A key element of the ECM in 
mesenchyme expansion is a GAG called hyaluronic acid (HA), as digestion of HA in 
cultured rat embryos causes cranial mesenchyme to collapse and a delay in neural tube 
closure (Morriss-Kay et al., 1986).  
Much like the “protoplasmic network” described by the Hertwig brothers in 1886, 
cranial mesenchyme and the ECM together form a porous meshwork made of star-shaped 
cells and intercalating strands of ECM components that support neural fold elevation 
during neurulation (Morriss and Solursh, 1978; Morris-Wiman and Brinkley, 1990a; 
Zohn and Sarkar, 2012). Mesenchyme is completely surrounded by ECM components, 
which do not function as an inert scaffold, but rather have been shown to profoundly 
influence cell fate (Assis-Ribas et al., 2018; Gattazzo et al., 2014; Hall and Watt, 1989; 
Wang and Chen, 2013; Watt and Huck, 2013). Integrins on the mesenchymal cell surface 
associate with PGs present in the ECM, which vary in concentration and composition 
throughout the extracellular network. Integrins also attract focal adhesion proteins which 
serve to associate the mesenchyme with cell signaling pathways and also the 
cytoskeleton, thereby allowing for proper cell migration in the expanding cranial tissue.  
Among other GAGs, HA has been demonstrated to maintain healthy mesenchyme 
development both in cell culture models and in vivo in rodents (Chen et al., 2007; 
Morriss-Kay et al., 1986; Morris-Wiman and Brinkley, 1990a). The matrices surrounding 
migrating and proliferating cells in the developing embryo are enriched in HA, which 
interacts with cell surface receptors CD44 and RHAMM to further stimulate cell 
morphogenesis and proliferation (Toole, 1997). With the exception of HA, all GAGs 
form PGs through covalent linkages with glycoproteins of the basement membrane, such 
as the collagens, fibronectin, laminins, biglycan, and tenascins. These different PGs 






cell movements, as well as controlling the diffusion of morphogens or providing binding 
sites for other elements of the ECM (Rozario and DeSimone, 2010).  
 
 
2.2 MATERIALS AND METHODS 
2.2.1 Mthfd1l Mouse Model  
This study used protocols approved by the Institutional Animal Care and Use 
Committee of the University of Texas at Austin, and care of animals was performed in 
accordance with the guidelines approved by the National Institutes of Health for the Care 
and Use of Laboratory Animals. All mice were maintained on a C57BL/6 genetic 
background, exposed to a 12-hour light/dark cycle, and fed commercially available 
laboratory chow (LabDiet 5K67). Heterozygous Mthfd1lz/+ mice were generated by 
crossing mice that harbored a floxed conditional cassette between exons 4 and 6 of the 
Mthfd1l gene with mice that expressed Cre recombinase under control of the E2a 
promoter (E2a-Cre), as previously reported (Momb et al., 2013).  
2.2.2 Mthfd1l Mouse Model Genotyping  
In order to genotype Mthfd1l mice, a forward primer (5’-
GAGTATGTGATTGCTTGGACCCCCAGGTTCC-3’), a reverse primer for wild-type 
alleles (5’-TGGCTCCCGAGGTTGTCTTCTGGCTATGAT-3’), and a reverse primer for 
mutant alleles (5’-CGGCGCCAGCCGCTTTTTTGTACAAACTTG-3’) were used. The 






2.2.3 Collection of Mthfd1l Embryos  
Heterozygous Mthfd1lz/+ mice were intercrossed to generate Mthfd1l+/+ and 
Mthfd1lz/z mouse embryos. Litters were generated by timed matings wherein 0.5 days of 
embryonic development (E0.5) had elapsed by noon of the day a copulation plug was 
observed. Pregnant females were sacrificed at both E8.75 and E9.5 for this study. They 
were killed by asphyxiation, and embryos were dissected from the uterus in chilled PBS 
under a Zeiss light dissection microscope. Embryos were rinsed in PBS and fixed in 4% 
paraformaldehyde in PBS at 4ºC overnight. 
2.2.4 Histology  
For histological analysis, fixed embryos were washed twice with room 
temperature PBS, then incubated in 70% EtOH for 5 minutes, 95% EtOH for 5 minutes, 
100% EtOH for 5 minutes twice, then incubated in Xylene Substitute (Histo-Clear, 
National Diagnostics) for 5 minutes twice. Following these steps, the embryos were then 
transferred into Peel-a-way disposable plastic embedding molds (Polysciences, Inc) 
containing melted paraffin at 60ºC, and were incubated in that paraffin for 5 minutes. The 
molten paraffin was then changed out, and the embryos were incubated again for 15 
minutes. This was repeated for one last incubation of 30 minutes, after which the paraffin 
was again replaced and embryos were oriented for embedding in cassettes used for 
sectioning with a microtome. Embryos were then sectioned at 7µm and mounted on 
positively charged glass microscope slides. Sections were then stained with 
Hematoxylin/Eosin (American Mastertech Scientific, Inc.) and imaged using a Nikon 
Eclipse Compound Microscope.  
 






Quantitative analysis of head mesenchyme cell density was carried out based on a 
previously described method (Dunlevy et al., 2006a). Cryo-sections of embryos were 
stained with DAPI and paraffin-embedded sections were stained with Hematoxylin and 
Eosin. Cell counting areas were defined as a percentage of the section being investigated 
by using boxes of defined dimensions located in a central site (8.5 % x 33.5 % of each 
section width) or a lateral site (8.5 % x 16.7 % of each section width). Image processing 
was conducted using ImageJ. 
2.2.6 Alcian Blue Staining  
Paraffin-sectioned embryos were deparaffinized with xylene substitute (Histo-
clear), and rehydrated using an ethanol series (100%, 95%, 70%). Slides were then rinsed 
with 3% acetic acid in order to protect the subsequent alcian blue solution from pH 
changes due to the introduction of water. Slides were incubated in 1% Alcian blue 
solution at pH 2.5 (Abcam) for 30 minutes at room temperature, and then rinsed briefly 
with 3% acetic acid to remove the excess Alcian blue. Slides were rinsed in running tap 
water for 10 minutes, and then rinsed briefly in distilled water. The slides were 
counterstained with Nuclear fast red solution (Millipore-Sigma) for 5 minutes. Slides 
were rinsed with distilled water, then dehydrated with 95% alcohol, followed by two 
100% alcohols, cleared with xylene substitute, and finally, cover-slipped. Alcian blue 
stained slides were imaged using a Nikon Eclipse Compound Microscope. 
2.2.7 Cryoembedding and Sectioning of Embryos  
Dissected embryos were placed in labeled glass vials, and fixed in 4% PFA in 






in 30% sucrose in PBS at 4°C overnight, or until the embryo sank to the bottom of the 
vial. The following morning, several drops of eosin were added to the sample in order to 
make the embryo more visible once it was embedded. One minute after eosin was added, 
the embryos were rinsed in PBS. The embryos were then incubated in a 1:1 mixture of 
OCT medium and 30% sucrose in PBS for 30 minutes on a rocking platform. Using the 
Zeiss light dissection microscope, embryos were properly oriented and embedded in OCT 
medium in cryomolds (Tissue-Tek), and flash frozen with ethanol and dry ice. The 
samples were stored at -80°C until they were sectioned. Immediately prior to 
cryosectioning, samples were stored at -20°C for 30 minutes.  
Samples were sectioned at 7µm using a CryoStar NX50 cryostat, with the blade 
oriented perpendicular to the coronal axis to obtain transverse sections of the cranial 
tissue. Samples were air-dried at least 30 minutes, and stored at -80°C in a sealed slide 
box until they were analyzed using immunohistological methods. 
2.2.8 Immunohistochemistry  
Slides with cryo-sectioned embryos were laid at least 1 cm apart in a humid 
chamber lined with wet paper towels. Once slides were at room temperature, they were 
rinsed with PBS-T (0.5% (v/v) Triton x-100 in PBS) for 2 minutes, twice. Slides were 
then blocked for non-specific binding with 5% Normal goat serum (Cell Signaling 
Technology) in PBS-T for 30 minutes at room temperature. The primary antibody to be 
used was then diluted to the desired concentration for that specific antibody in 1% serum 
in PBS-T, and 75µL of the diluted primary antibody was added to each slide. The 
following primary antibodies were used: anti-collagen, type I (Millipore, 1:40 dilution), 
anti-collagen, type IV (Millipore, 1:50 dilution), anti-fibronectin (Millipore, 1:80 






The slides were incubated in the desired primary antibody overnight at 4°C in the 
sealed humid chamber. The next morning, slides were washed twice with 1% serum-
containing PBS-T for 10 minutes each. The secondary antibody used was goat anti-
mouse Alexa Fluor 488 (Life Technologies), which was diluted 1:200 in 1% serum-
containing PBS-T; 75µL of this dilution was added to each slide. They were incubated 
for 1 hour in the dark at room temperature. Slides were then washed twice with 1% 
serum-containing PBS-T for 10 minutes each. Excess wash was tapped off the slides and 
one drop of anti-fade mounting medium with DAPI (Vectashield) was added to the slide, 
and coverslips were applied (VWR).  
Images were taken with a Zeiss Axiovert Inverted Fluorescent Light microscope, 
or a Zeiss 750 Laser Scanning Confocal microscope. Images were analyzed using ImageJ 
software (U.S. National Institutes of Health). Vimentin fluorescence intensity was 
expressed as corrected total cell fluorescence: background fluorescence was subtracted 
from total vimentin signal in mesenchyme, then normalized by area or number of cells 





2.2.9 Statistical Analysis 
 To evaluate the Mendelian ratio of Mthfd1l-mutant embryos born and collected in 
this study, the Chi-squared goodness of fit test was used. For all other experiments in this 






variance), or Mann-Whitney U test. All statistical tests were performed using Prism 
version 8 (GraphPad, La Jolla, CA). 
2.3 RESULTS 
2.3.1 Mice Lacking Mthfd1l Show Delayed Growth and Developmental Progression 
 In order to evaluate the mechanism of action of Mthfd1l during NTC, embryonic 
litters were collected immediately before and after E9.5, which is the approximate 
embryonic day when neural tube closure occurs in the mouse. Analysis of these embryos 
at various developmental stages showed that Mthfd1lz/z embryos have a reduced somite 
number compared with WT littermates, and an open neural tube at E10.5. The genotypic 
distribution across embryos did not follow Mendelian ratios for inheritance of the 
Mthfd1lz allele, and the observed ratio of Mthfd1l+/+: Mthfd1lz/+: Mthfd1lz/z was 91:134:51 
(Table 2.1).  A Chi-squared goodness of fit test reflected a p-value of 0.0008, indicating 
that the Mthfd1lz/z genotype causes embryonic death prior to E9.5. This is consistent with 
previous work with the Mthfd1l mouse model (Momb et al., 2013). Because Mthfd1lz/z 
mice develop more slowly than their WT littermates, somite matching was used to 
standardize comparisons across genotypes. At E9.5, Mthfd1lz/z mice are at the same 
somite stage of development as E8.75 WT mice (Figure 2.2), so in this chapter these ages 











Table 2.1: The Mthfd1lz/z genotype causes embryonic death prior to E8.5. Genotype 
distribution of litters from breeding of Mthfd1lz/+ mating pairs over a one-


















































         
Figure 2.2. Mthfd1l nullizygous mice are smaller than wild-type littermates and have 
an open neural tube. Compared with wild-type embryos, Mthfd1lz/z embryos 
show delayed growth and developmental progression at all embryonic stages 
(E7.5 to E10.5). Mthfd1lz/z embryos at E9.5 have similar morphology with 
Mthfd1l+/+ embryos at E8.75. Mthfd1lz/z embryos at E10.5 are similar in size with 







2.3.2 Mthfd1l Deletion Leads to Reduced Density of Cranial Mesenchyme  
The head mesenchyme in Mthfd1lz/z embryos appeared sparser in the vicinity of 
the neural plate, especially underneath the neural plate. To examine the cell density of 
head mesenchyme with high morphological preservation, paraffin embedded and 
subsequent histological methods were utilized. Transverse paraffin sections of 7-13 
somite stage Mthfd1l+/+ and Mthfd1lz/z embryos were stained with Hematoxylin and eosin 
(H&E) to visualize nuclei, and cell density in the head mesenchyme was quantified 
(Figure 2.3 a, b). The total mesenchyme density was significantly lower in the mutant 
embryos compared to wild-type embryos (Figure 2.3 e). The decrease in cell density was 
most apparent in the mesenchyme underlying the neural plate (Figure 2.3 a, b). The 
apparent difference around the lateral edges of neural plate (Figure 2.3 d) did not reach 
statistical significance. These data suggest that the development of the head mesenchyme 
is abnormal in Mthfd1lz/z embryos, as evidenced by a total reduction in mesenchymal cell 








Figure 2.3. Deletion of Mthfd1l causes reduced head mesenchyme density at 7-13 
somite stages. Representative transverse paraffin-embedded sections of 
wild type (A) and nullizygous embryos (B) show reduction in number of 
mesenchymal cells of nullizygous embryos in the cranial region. Straight 
line in the embryos (A-B) indicates the level of sections. Head mesenchyme 
density is significantly different in the central area as well as the total 
mesenchyme (C-E). Sections were stained with hematoxylin and eosin. n = 
three embryos in each genotype with three sections analyzed per embryo. 













2.3.3 Deletion of Mthfd1l Causes a Reduction in Vimentin Expression 
 
Vimentin expression was used as a marker for mesenchyme to further explore the 
defect in head mesenchyme development. At mouse embryonic day 8.5, vimentin 
expression is observed in cells of the primary mesenchyme and neural crest (Franke et al., 
1982). Cryo-sections of 7-13 somite stage embryos were stained with anti-vimentin 
antibodies (Figure 2.4, upper panel).  The fluorescence intensity of vimentin staining 
normalized by cell number in mesenchyme showed a trend toward higher vimentin 
expression in WT embryos, but did not reach significance (Figure 2.4, lower right panel; 
p = 0.09). However, when the intensity was normalized by mesenchyme area, vimentin 
expression was significantly lower in nullizygous embryos compared with WT embryos 
(Figure 2.4, lower left panel; p < 0.05).  These data indicate that mitochondrial formate 
production via Mthfd1l is important in determining the density of cells that populate the 
cranial mesenchyme. 
50
Figure 2.4. “Vimentin expression is reduced in Mthfd1l mutant embryos at 7-13 
somite stages. Representative transverse cryo-sections of Mthfd1+/+ (wild-type) 
and Mthfd1z/z (nullizygous) embryos were stained for vimentin and DAPI for 
nuclei. In the merged images, vimentin staining is green and DAPI staining is 
blue. Straight line in the whole embryos indicates the level of sections. Lower 
panel: fluorescence intensity of vimentin staining in the cranial region was 
normalized by mesenchyme area (left) or by mesenchyme cell number (right). n = 
three embryos in wild type and five embryos in nullizygotes with three sections 






2.3.4 Deletion of Mthfd1l Diminishes Hyaluronic Acid Content in the Extracellular 
Matrix 
 Following our discovery of a mesenchyme defect in the Mthfd1z/z embryo, the 
ECM was examined as a possible source of mesenchyme depletion. As HA has been 
shown to influence mesenchyme integrity during development (Morriss-Kay et al., 1986), 
abnormal HA concentration in the Mthfd1z/z cranial tissue might be associated with the 
observed reduction in mesenchyme cell number. Alcian blue staining of paraffin-
sectioned embryos at the time of NTC was performed, and sections were qualitatively 
compared for differences in HA composition. Nuclear Fast Red stain was used as a 
counterstain. Compared to Mthfd1+/+ sections, Mthfd1z/z embryos appear to have a 










Figure 2.5. Alcian blue staining indicates a reduction in HA concentration 
surrounding the cranial mesenchyme of Mthfd1z/z embryos. Top panel: 
Mthfd1+/+ embryo with Representative transverse paraffin section of cranial 
tissue, stained with alcian blue and nuclear fast red. Bottom panel: Mthfd1z/z 
embryo with Representative transverse paraffin section of cranial tissue, stained 










2.3.5 Immunohistochemistry of Extracellular Matrix Proteins  
2.3.5.1 Mthfd1l Deletion Does Not Significantly Alter Fibronectin Expression 
The extracellular matrix protein fibronectin is a principle component of the 
basement membrane that surrounds mesenchymal cells and plays an essential role in 
convergent extension during neural tube closure (Dady et al., 2014; Tada and Heisenberg, 
2012). Mouse embryos lacking fibronectin exhibit a lack of somite condensation, as well 
as defects in neural tube morphogenesis, mesoderm specification, and yolk sac 
vasculature—they live until the approximate age of neural tube closure, E9.5 (Davidson 
et al., 2006; George et al., 1993; Georges-Labouesse et al., 1996; Le A. Trinh and 
Stainier, 2004; Linask and Lash, 1988a, 1988b).  
Because a defect was observed in the glycosaminoglycan composition of the 
ECM of Mthfd1l-null embryos (Figure 2.5), fibronectin was analyzed to determine if 
ECM proteoglycan expression was also compromised, and if it may be related to the 
observed growth defects in these embryos. Twelve embryos, 6 of each genotype, were 
cryosectioned and analyzed using immunohistochemical methods, and fluorescence 
intensity was calculated and normalized to tissue area for each sample (µm2). Three 
sections per embryo were analyzed to give one averaged value per biological replicate. 
There was a slight reduction in fibronectin expression in Mthfd1l-null embryo cranial 











Figure 2.6. Fibronectin expression does not differ significantly between WT and 
Mthfd1l-null embryos. Fibronectin expression as measured by area in transverse 
cryosections of cranial tissue of WT and Mthfd1l-null embryos. The fluorescence 
intensity of fibronectin as shown in green in WT (left) and Mthfd1l-null (right) 
embryos is not significantly different (lower panel). Biological replicates of n=6 
WT (circles) and null (squares) embryos were analyzed. Yellow lines indicate 
plane of section in embryonic cranial tissue evaluated. P values were calculated 






















2.3.5.2 Mthfd1l Deletion Significantly Alters Collagen IV Expression 
Of all proteins in the animal kingdom, collagens are the most abundant. Mice 
lacking Collagen I do not live beyond E12, and exhibit mesenchymal cell death and 
defects in vascularization (Liu et al., 1995; Löhler et al., 1984; Schnieke et al., 1983); 
whereas those without Collagen IV (ColIV) expression die earlier, just before E10, and 
have defects in basement membrane integrity (Cosgrove et al., 1996; Miner and Sanes, 
1996; Pöschl et al., 2004; Rheault et al., 2004). Because ColIV affects embryonic 
development in mice at an earlier stage, I first evaluated the possible association of 
Mthfd1l deletion and ColIV scaffolding in the basement membrane. Additionally, 
embryonic expression of ColIV has been associated with proliferation during 
development (Chamoux et al., 2002), therefore immunostaining was carried out to see if  
ColIV expression was altered in Mthfd1lz/z embryos. Nine WT embryos were 
cryosectioned and stained, and seven Mthfd1lz/z embryos were also analyzed. 
Flourescence intensity values (CTCF) per tissue area (µm2) were evaluated in 3 sections 
per embryo, and averaged to give a final data point for each biological replicate. Mann-
Whitney U analysis showed that there was a statistically significant lower Collagen IV 














Figure 2.7. Collagen IV expression is significantly decreased in Mthfd1l-null 
embryos. Collagen IV expression as measured by area in transverse cryosections 
of E9.5 WT and Mthfd1l-null embryos. The fluorescence intensity of Collagen IV 
as shown in green in WT (left) and Mthfd1l-null (right) embryos is significantly 
different (lower panel). Biological replicates of n=9 WT (circles) and n=7 null 
(squares) embryos were analyzed. Yellow lines indicate plane of section in 
























 Mthfd1l is expressed at all stages during embryogenesis, and when it is defective, 
we observed neural tube defects, a delay in growth, and embryonic death at day E12.5 in 
the mouse (Momb et al., 2013). The biochemical mechanism by which Mthfd1l is 
associated with embryonic growth and neurulation is unknown, although one possible 
source of dysregulation is aberrant methylation. Mthfd1l is responsible for generating 
mitochondrial formate, which accounts for more than 75% of the 1C units that enter the 
methyl cycle (Pike et al., 2010). Around the time of neural tube closure, the mesenchyme 
in Mthfd1l-null mouse embryos is less dense (Figure 2.3), which parallels observations of 
methyl cycle disruption in mouse embryos at a similar age (Dunlevy et al., 2006b, 
2006a). The methyl cycle is the source of the universal methyl donor S-adenosyl 
methionine (AdoMet), which is required for histone and DNA methylation, processes 
intrinsically linked to cell differentiation and migration (Horswill et al., 2008; 
Kobayakawa et al., 2007). Furthermore, aberrant DNA methylation in embryonic brain 
tissue has been associated with impaired maternal folate metabolism and the occurrence 
of NTDs (Chang et al., 2011; Lin et al., 2019; Wang et al., 2015). Because a large 
number of genes are involved in cranial neurulation (Copp et al., 2003), epigenetic 
dysregulation of any of these may result in embryonic cranial defects or exencephaly. In 
separate studies of methionine deficiency in rat embryos, it was demonstrated that 
AdoMet-dependent methylation of cytoskeletal proteins β-actin and tubulin are required 
for NTC (Coelho and Klein, 1990; Moephuli et al., 1997). Inhibition of the methyl cycle 
has also caused NTDs in the chick model (Afman et al., 2005), hence DNA and protein 
methylation are essential for NTC to occur properly, and decreased flux through the 






 The observed reduction of cranial mesenchyme cell density of Mthfd1l-null 
embryos (Figure 2.3, 2.4) may contribute to the development of exencephaly, as the 
elevation of neural folds is likely supported by the layer of mesenchyme below the 
neuroepithelium (Copp, 2005; Copp et al., 2003). This possibility is supported by the 
observation that digestion of hyaluronic acid (HA) in cultured rat embryos caused 
mesenchyme to collapse and delayed neural tube closure (Morriss-Kay et al., 1986). In 
our mouse model, we observed a decrease in mesenchyme density and lower HA 
abundance and distribution in the Mthfd1l-null embryo (Figure 2.5), both of which may 
contribute to the growth defect and open neural tube at E10.5. Based on these findings, 
we propose a model describing the relationship between Mthfd1l and NTC, wherein 
Mthfd1l expression in the neuroepithelium and underlying paraxial mesoderm leads to a 
high density of mesenchyme cells and adequate distribution of HA, allowing for neural 
plate elevation and DLHP formation (Figure 2.8). A lack of Mthfd1l expression 
throughout the paraxial mesoderm and neuroepithelium leads to a reduction in 
mesenchyme density, which produces insufficient forces on the neural plate to result in 
NTC. This model is only applicable to cranial neural tube closure, as mesenchyme 
expansion does not accompany spinal neural tube closure, and removal of the paraxial 
mesoderm also does not affect spinal neural tube closure (Copp et al., 2003; van Straaten 









Figure 2.8. “Schematic illustration of the cranial mesenchyme during neural fold 
elevation. (left) Normal elevation of neural plates is supported by head 
mesenchymal cells in wild type embryos. (right) Apposition and fusion of neural 
plates are failed in Mthfd1l nullizygotes. Neuroepithelium and mesenchyme are 
shown in dark and light pink, respectively. Yellow shading in panel A indicates 
Mthfd1l expression. Arrows indicate physical forces generated by mesenchyme 
acting on the neural plates that drive neural fold elevation.” 
According to our model, in the absence of Mthfd1l expression, a reduction of 
mitochondrially-derived formate likely decreases flux through the 1C and methyl cycles, 
which retards development due to impaired biosynthesis as well as AdoMet-dependent 
epigenetic regulation and protein methylation, ultimately resulting in decreased cranial 
mesenchyme density. Aside from methyl cycle impairment (Dunlevy et al., 2006b, 
2006a), the additional cellular mechanisms involved that cause reduction in cranial 
mesenchyme remain unknown. In past experiments, our lab examined proliferation, 
neural crest cell migration, and apoptosis, and found no major difference between WT 
and Mthfd1l-null embryos prior to neural tube closure (Shin, 2016). In this chapter, I 
explored the hypothesis that the ECM may be altered in the absence of Mthfd1l 
expression, as mesenchyme cells are surrounded by glycosaminoglycans (GAGs), 






Solursh, 1978). Because HA has been reported to influence the proliferation, migration, 
adhesion, and differentiation of mesenchyme (Chen et al., 2007; Knudson, 2003; Morris-
Wiman and Brinkley, 1990a; Nilsson et al., 2003; Peck and Isacke, 1996), the diminished 
HA distribution observed in Mthfd1l nullizygous embryos may contribute to their 
impaired mesenchymal cell development. HA is enriched in developing tissue (Toole, 
1997), and interacts with cells directly during embryogenesis directly via the receptor 
CD44 (Knudson, 2003). In order to further investigate the role of HA on reduced 
mesenchyme and failed neural tube closure, immunohistochemical staining of CD44 in 
Mthfd1l-null mesenchyme would more clearly indicate the extent of cell-matrix 
interactions.  
The most abundant protein in the ECM is collagen, which contains a polypeptide 
chain with glycine as every third amino acid (~33% of the residues). Mthfd1lz/z embryos 
produce approximately half the amount of glycine as WT embryos (Bryant et al., 2018), 
which may affect collagen production as well. In this study, we found Collagen IV 
expression to be decreased in the absence of Mthfd1l (Figure 2.7), which is consistent 
with the hypothesis that glycine is required for collagen synthesis. We also examined the 
expression of fibronectin, another ECM protein required for embryogenesis and somite 
formation (George et al., 1993; Georges-Labouesse et al., 1996), however expression 
levels between null and WT cranial tissue were not significantly different (Figure 2.6).  
In the future, immunohistochemical analysis of Collagen I expression would 
reveal if the phenomenon of decreased collagen expression is universal to all collagens, 
or specific to Collagen IV. Collagen I is associated with mesenchymal cell death, and like 
Collagen IV, Collagen I loss is embryonically lethal (Liu et al., 1995; Löhler et al., 1984; 
Schnieke et al., 1983).  Another ECM protein associated with NTC is Laminin α5, which 






knockout mouse models have resulted in exencephaly, among other embryonic defects 
(Miner et al., 1998; Webb et al., 2007). It would be interesting to determine if Laminin α5 
is altered in the Mthfd1lz/z embryo, as like Collagen IV, Laminin α5 is a component of the 
basement membrane, which lines the neuroepithelium and may be associated with the 
birth defects observed in the absence of Mthfd1l expression during development. 
Interestingly, proliferation of human fetal adrenal cells was induced with the addition of 
Collagen IV or Laminin α5 to the culture matrix; conversely, fibronectin encouraged 
apoptosis in the same cells in culture (Chamoux et al., 2002). 
Finally, lineage tracing of the neural crest and paraxial mesoderm populations that 
form the mesenchyme would shed light on the mechanism of neural fold elevation and 
mesenchyme development. In the Mthfd1l-null mouse, the cause of reduced cranial 
mesenchyme density is not yet fully understood, therefore fate-mapping of the cells that 
ultimately form mesenchyme and elevate the neural folds is a way to explore the onset of 
this phenotype. This experiment can be done using Wnt1-cre and Mesp1-cre transgenic 
mouse lines to differentiate the neural crest and paraxial mesoderm, respectively, as 
described previously (Yoshida et al., 2008). These mouse lines can be bred with our lab’s 
Mthfd1lz/+mouse in order to elucidate why the Mthfd1lz/z mouse has reduced mesenchyme 
density and failed elevation of the neural folds. Furthermore, this experiment will isolate 












CHAPTER 3: DESI-IMS OF MTHFD1L-NULL EMBRYOS 
3.1 INTRODUCTION 
Cell proliferation and differentiation are concurrent processes during 
development, and both greatly depend on metabolism (Agathocleous and Harris, 2013; 
Tennessen et al., 2011). One of the main functions of 1C metabolism is to provide 
anabolic intermediates for the biosynthesis of purines, thymidylate, and AdoMet, all of 
which are in great demand as cells proliferate and differentiate rapidly to meet the needs 
of a developing organism. In an effort to understand the metabolic processes disrupted by 
Mthfd1l deletion, our lab has performed untargeted metabolomics on whole WT and 
Mthfd1l-null embryos previously (Bryant et al., 2018). NMR and LC-MS analyses of 
whole embryo samples and mouse embryonic fibroblasts (MEFs) indicated that deletion 
of Mthfd1l leads to perturbations in amino acid metabolism, the TCA cycle, glycolysis, 
and 1C metabolism (Bryant et al., 2018). Comprehensive embryo metabolome analysis 
sheds light on how metabolism is altered in Mthfd1l-null embryos; however, because 
neural tube closure is driven by a number of morphogenetic processes, the spatial 
organization of the tissue is particularly relevant and should be taken into consideration 
in metabolic pathway analyses. 
Recent technical advances in mass spectrometry have allowed for visualization of 
metabolism in vivo via imaging mass spectrometry (IMS). There is one report of the use 
of IMS on embryonic murine tissue, which revealed an increase in pools of citrate and 
lactate between E8.5 and E10.5, suggesting that glycolysis is upregulated during neural 
tube closure (Miyazawa et al., 2017). In that experiment, lactate was shown to 
accumulate along the dorsal neural tube and in the cranial mesenchyme at the time of 






glycolysis inhibition in cultured embryos (Hunter and Tugman, 1995). Interestingly, our 
comprehensive metabolome study indicated that Mthfd1l-null MEFs have significantly 
decreased flux through glycolysis (Bryant et al., 2018). Although it is known that 1C 
metabolism, energy metabolism, and amino acid metabolism are altered in the Mthfd1l-
null embryo, the metabolic flaws that result in aberrant neural tube formation remain 
elusive. The neural tube can be analyzed directly using IMS, offering a mechanistic link 
between 1C metabolism and morphology during development. In this chapter, I describe 
my collaboration with Rachel Dehoog of Dr. Livia Eberlin’s lab, in which we use IMS to 
identify significantly altered metabolites in the cranial neural tube of the Mthfd1l-null 
mouse model that may contribute to the occurrence of NTDs. Ultimately, this work can 
be combined with future efforts to address how metabolism is coordinated with 
development. 
3.2 MATERIALS AND METHODS 
3.2.1 DESI-based Imaging Mass Spectrometry (IMS) 
In order to prevent excessive background signal detection from fixative materials, 
embryos were not fixed, but rather transferred directly into optimal cutting temperature 
(OCT) embedding medium, flash frozen with dry ice and ethanol, and stored at -80°C. 
Eight mouse embryos including 4 wild type and 4 null were sectioned at a thickness of 
16µm using a CryoStar NX50 cryostat and stored at -80°C until analysis. Embryo 
sections were thawed at room temperature for ~10 minutes before desorption electrospray 
ionization mass spectrometry (DESI-MS) analysis. Sections were then imaged in the 
Eberlin lab with DESI-MS using a Q Exactive Orbitrap mass spectrometer (Thermo 
Fisher Scientific, CA) fitted with a 2D Omni spray stage (Prosolia Inc., IN) and a lab-






the negative ion mode with a mass range of m/z 100-1,500 at a resolving power of 
70,000. The solvent system of acetonitrile:dimethylformamide (ACN:DMF) 3:1 (v/v) 
was used at a flow rate of 1.2 µL/min. The N2 pressure set to 180psi. Ion images were 
assembled using Firefly and Biomap software. Ions were tentatively identified using high 
mass accuracy measurements and/or tandem mass spectrometry using higher-energy 
collisional dissociation (HCD).  
After DESI-MS analysis, tissue sections were hematoxylin and eosin (H&E) 
stained and examined using light microscopy to identify sections containing cranial 
mesenchyme cell populations. Furthermore, Tandem Mass Spectrometry (MS/MS) was 
used following IMS analysis to confirm the identity of metabolites discovered by DESI. 
3.2.2 Statistical Analysis for IMS 
Three sections per embryo in the area of interest were selected to use for 
statistical analysis. One null embryo was excluded from statistical analysis due to its 
smaller size and low DESI-MS signal. For each section, 10 mass spectra corresponding to 
mesenchyme histology were extracted using MSiReader software. The data was then 
imported into R language where the mass range was discretized by binning each m/z 
value to the nearest hundredth. In this process, m/z bins that appeared in less than 10% of 
pixels were excluded and each mass spectrum was normalized to the median non-zero 
intensity, and then the logarithm of these normalized intensity values was taken.  
Significance analysis of microarrays (SAM) analysis was performed in R using 
the SAM function from the samr library (Eberlin et al., 2014). A false discovery rate 
(FDR) of 0.05 was used to identify significant m/z values with altered abundances 






from 10 mass spectra that corresponded to mesenchyme-containing regions, as explained 
in the above paragraph. 
At this point, an average mass spectrum was calculated for each section and 
principal component analysis (PCA) was performed using the prcomp function in R. PCA 
was performed on the total average mass spectra, as well as on the 10 mass spectra that 
corresponded to mesenchyme-containing regions. 
 
3.3 RESULTS 
3.3.1 DESI-MS of Embryonic Cranial Mesenchyme 
Our lab has previously conducted non-targeted metabolomics screens of whole 
Mthfd1lz/z embryos using NMR and MS (Bryant et al., 2018). Because the results of that 
study were not specific to our region of interest, the following MS-based experiments in 
this chapter are concerned with isolating regions where phenotypic differences exist in 
the Mthfd1lz/z mouse model; specifically, we directly analyzed metabolomics of the 
cranial mesenchyme using DESI-IMS. 
Embryos were dissected around the time of neural tube closure and embedded in 
cryogenic OCT medium without fixing to avoid contamination of the MS signal during 
molecule detection. Once the embryos were sectioned, they were mounted on slides and 
the spatial metabolome of these samples were investigated with negative ion mode DESI-
MS in the m/z range 100 to 1,500.  The embryo tissue sections were sprayed with 
microdroplets of dimethylformamide:acetonitrile (1:1) solvent, which is histologically 
compatible and allows for H&E staining to be completed following DESI analysis 






microdroplets that are analyzed by MS to produce a chemical map of the sample. The 
IMS-produced ion maps give spatial relevance to metabolism, providing information 
regarding the abundance and distribution of each m/z detected by this process. 
 
 
Figure 3.1. Experimental design for targeted DESI-IMS of mouse embryonic cranial 
mesenchyme. From left to right, following DESI-MS of sectioned cryoembedded 
embryos on microscope slides, visual spectra of region are viewed atop H&E 
stain of embryo section. Ten spectra that align with mesenchyme tissue are 
selected, and the average intensities of these spectra are used in PCA and SAM 
analysis. 
  
As outlined in Figure 3.1, once both chemical mapping by DESI-IMS and H&E 
staining were completed, an overlay of the two images was used to identify the pixels 
correlating to the regions of the tissue containing mesenchyme. Ten pixels were selected 
for each sample, and these ten spectra were averaged for each sample, yielding an 
averaged mesenchyme spectrum. The averaged mesenchyme spectra of all samples from 
each group (WT: n=12; Mthfd1l-null: n=9) were averaged to produce a DESI-MS spectra 
of metabolites found in the mesenchyme (Figure 3.2). Given the hundreds of data points 
obtained by this method, the subtle (and some not-so-subtle) differences in metabolism 






themselves, however the alterations in specific metabolism were further explored by 
SAM analysis.  
  
 
Figure 3.2. DESI-MS Spectra of Embryonic Cranial Mesenchyme. Averaged spectra 
of ions detected in WT (top panel) and Mthfd1l-null (bottom panel) embryos with 
optimized DESI-MS parameters. Mass spectra are averages of 10 pixels extracted 








3.3.2 SAM Analysis 
In order to process the plethora of data obtained by DESI-MS, we used the 
significance analysis of microarrays (SAM) method to select those metabolites with 
statistically significant increased or decreased abundance in the Mthfd1l-null embryo 
sections. This method is a useful means to compare differences between two large data 
sets, and was performed using R as previously described (Eberlin et al., 2014). From our 
data, SAM selected 516 molecular ions that were significantly increased or decreased in 
the Mthfd1l-null embryos compared to WT embryos with a FDR of less than 5%. Of the 
selected ions, 437 were significantly decreased in the nullizygous embryos, and 79 were 
significantly increased. Tandem mass spectrometry was used to confirm the identify of 
some of the biologically relevant selected ions using fragmentation pattern analysis. The 
majority of metabolites identified by SAM reflected a decrease in abundance in the 










Figure 3.3. SAM analysis of metabolites of Mthfd1l-null and WT embryos using R. 
Metabolite ions with significantly different abundance that were selected by SAM 
analysis are organized by m/z values along the x-axis, with the corresponding 
SAM score along the y-axis. Some of the metabolites selected were increased in 
the null samples and were given positive SAM scores (green) and some 




























Table 3.1: Metabolite species selected by SAM as increased or decreased in the 
cranial mesenchyme of Mthfd1lz/z embryos (FDR < 5%) identified using 
DESI-IMS. SAM scores in the negative range indicate metabolites 
downregulated in Mthfd1lz/z embryos and positive range indicate 
upregulation in Mthfd1lz/z embryos compared to WT. 











Uracil -5.723 111.019 111.020001 C4H4N2O2 9.0 
Proline -7.88 114.055 114.056053 C5H9NO2 9.2 
Fumarate 2.011 115.002 115.0037 C4H4O4  -14.8 
Succinate -3.71 117.018 117.019333 C4H6O4 11.4 
Taurine -2.446 124.006 124.007 C2H6NO3S 8.1 




-3.475 130.05 130.050967 C5H9NO3 7.4 
Ureidopropionic acid or 
Asparagine 





-1.455 131.045 131.0462 C4H8N2O3 9.2 
Adenine -13.649 134.046 134.047219 C5H5N5 9.1 
Threonic acid or 
Erythronic acid 
-2.418 135.029 135.0299 C4H8O5 6.7 
Phenylacetate, 
Ethenylbenzenediol 
-3.751 135.044 135.045153 C8H7O2 8.5 
Glutamine -1.447 145.061 145.062 C5H9N2O3 6.9 
Hydroxyheptanoic acid -3.055 145.086 145.087018 C7H14O3 7.0 




-6.575 166.017 166.017952 C4H9NO4S 5.7 
Ascorbic acid 3.705 175.024 175.0248 C6H8O6 -4.6 
Glucose -4.693 179.055 179.056112 C6H12O6 6.2 
L-Iditol/Galactitol/ 
Mannitol/Sorbitol 
4.616 181.071 181.0718 C6H14O6 -4.4 
L-methionine -4.328 190.054 190.054338 C7H13NO3S 1.8 
Citrate/Isocitrate 1.9 191.019 191.0197 C6H8O7 -3.7 
Gluconic Acid 2.72 195.05 195.051 C6H12O7 -5.1 












-2.489 201.149 201.1496 C11H22O3 3.0 
Undecanedioic acid, 
Butyl butyryllactate 
-5.225 215.128 215.128883 C11H20O4 4.1 
Pantothenic acid 
(vitamin B5) 
2.633 218.103 218.1034 C9H17NO5 -1.8 
Trihydroxyquinoline-
carboxylic acid 
-7.228 220.026 220.025146 C10H7NO5 -3.9 
Phosphatidic acid or 
citrate 
10.061 226.996 226.9964 C6H8O7Cl -1.8 
Glycerol 1-propanoate 
diacetate 
-1.846 231.087 231.0874 C10H16O6 1.7 
S-Cysteinosuccinic acid -1.786 236.021 236.0234 C7H11NO6S 10.2 
Uridine  -1.429 243.062 243.0623 C9H12N2O6 1.2 
Palmitate (FA(16:0)) -1.957 255.233 255.233 C16H31O2 0.0 
Ribothymidine -1.837 257.076 257.0779 C10H14N2O6 7.4 
Deoxyuridine -1.881 263.044 263.044 C9H12N2O5Cl 0.0 
FA(16:0(OH)) -2.001 271.228 271.2279 C16H32O3 -0.4 
L-Thyronine 3.72 272.094 272.0928 C15H15NO4 4.4 
Glutaminylproline 1.975 278.093 278.0913 C10H17N3O4Cl 6.1 
FA(18:1) -5.043 281.249 281.248604 C18H32O2 -1.4 
Glutamylhistidine -4.537 283.104 283.104794 C11H16N4O5 2.8 
FA(18:3(OH)) -1.31 293.212 293.2122 C18H30O3 0.7 
Nonadecanedione -3.375 295.264 295.264254 C19H36O2 0.9 
Hydroxyoctadecanoic 
acid 
-4.169 299.259 299.259169 C18H36O3 0.6 
MG(14:0) -1.374 301.238 301.2384 C17H34O4 1.3 
FA(20:4) -5.851 303.233 303.233 C20H32O2 0.0 
FA(20:3) -6.197 305.249 305.2486 C20H34O2 -1.3 
Glutathione (GSH) 2.658 306.076 306.0765 C10H17N3O6S -1.6 
FA(20:2) -6.781 307.264 307.2643 C20H36O2 1.0 
FA(20:1) -4.661 309.28 309.2799 C20H38O2 -0.3 
FA(20:0) -3.299 311.296 311.2956 C20H40O2 -1.3 
FA(21:5) -4.438 315.233 315.232954 C21H32O2 -0.1 
FA(18:1) -1.311 317.226 317.2253 C18H34O2Cl -2.2 
FA(20:3(OH)) -1.932 321.244 321.2437 C20H34O3 -0.9 






(Table 3.1 continued) 
 
     
MG(16:1) -1.852 327.254 327.2541 C19H36O4 0.3 
FA(22:5) -6.764 329.249 329.2486 C22H34O2 -1.2 
FA(22:4) -6.69 331.264 331.2643 C22H36O2 0.9 
FA(22:3) -4.467 333.28 333.2799 C22H38O2 -0.3 
FA(22:2) -3.039 335.296 335.2956 C22H40O2 -1.2 
MG(14:0) -3.054 337.215 337.215112 C17H34O4Cl 0.3 






-2.343 346.056 346.0558 C10H14N5O7P -0.6 
FA(24:6) -4.991 355.264 355.2643 C24H36O2 0.8 
FA(24:5) -5.539 357.28 357.2799 C24H38O2 -0.3 
FA(24:4) -5.283 359.296 359.2956 C24H40O2 -1.1 
FA(24:3) -4.452 361.312 361.3112 C24H42O2 -2.2 
FA(22:6) -4.072 363.21 363.2096 C22H32O2 -1.1 
MG(16:1) -2.688 363.231 363.230762 C19H36O4Cl -0.7 
FA(24:2) -3.761 363.327 363.3269 C24H44O2 -0.3 
MG(16:0) -3.278 365.246 365.246412 C19H38O4Cl 1.1 
FA(26:6) -5.814 383.296 383.2956 C26H40O2 -1.0 
FA(26:5) -4.057 385.311 385.3112 C26H42O2 0.5 
MG(18:3) -2.575 387.231 387.2308 C21H36O4Cl -0.5 
FA(26:4) -4.45 387.327 387.3269 C26H44O2 -0.3 
MG(18:2) -3.671 389.247 389.246412 C21H38O4Cl  
FA(26:3) -1.764 389.343 389.3425 C26H46O2 -1.3 
FA(26:2) -1.837 391.359 391.3582 C26H48O2 -2.0 
11-
Hydroxyeicosatetraenoa
te glyceryl ester 
-3.907 393.262 393.264648 C23H38O5 6.7 
FA(28:6) -3.835 411.327 411.326855 C28H44O2 -0.4 
FA(28:5) -4.775 413.343 413.3425 C28H46O2 -1.2 
Palmitoyl glucuronide  -10.428 417.287 417.285778 C22H42O7 -2.9 





-4.182 423.275 423.275213 C24H40O6 0.5 
MG(22:6) -5.541 437.247 437.246412 C25H38O4Cl -1.3 






(Table 3.1 continued)  
 
    
FA(30:6) -2.369 439.36 439.3582 C30H48O2 -4.1 
FA(30:5) -4.019 441.375 441.3738 C30H50O2 -2.7 
FA(32:6) -3.685 467.389 467.3895 C32H52O2 1.1 
LPG(O-16:0) -2.555 469.292 469.2936 C22H47O8P 3.4 
FA(32:5) -4.336 469.406 469.4051 C32H54O2 -1.9 
PS(P-16:0) -1.753 480.273 480.2732 C22H44NO8P 0.4 
LysoPE(18:0) 2.75 480.311 480.3096 C23H48NO7P 2.9 
FA(34:6) -4.168 495.42 495.4208 C34H56O2 1.6 
FA(34:5) -3.653 497.437 497.4364 C34H58O2 -1.2 
Oleic acid + palmitic 
acid dimer 
-4.117 537.49 537.489 C34H65O4 -1.9 
Cer(d34:1) 2.836 572.482 572.4815 C34H67NO3Cl 0.9 
DG(32:1) -2.34 601.462 601.4604 C35H66O5Cl -2.7 
DG(32:0) -2.076 603.477 603.4761 C35H68O5Cl -1.5 
DG(34:2) -2.038 627.477 627.4761 C37H68O5Cl -1.4 
Cer(d38:1) -1.531 628.547 628.5441 C38H75NO3Cl -4.6 
Cer(d40:1) 1.941 656.576 656.5754 C40H79NO3Cl 0.9 
Cer(d42:2) 2.376 682.592 682.5911 C42H81NO3Cl 1.3 
Cer(d42:1) 3.374 684.609 684.6067 C42H83NO3Cl 3.4 
PE(32:1) -1.977 688.492 688.4923 C37H72NO8P 0.4 
CL(68:4) -2.367 699.478 699.4788 C77H142O17P2 1.1 
PE(O-34:2) or PE(P-
34:2) 
-3.079 700.528 700.5287 C39H76NO7P 1.0 
CL(68:0) -2.675 703.509 703.5101 C77H150O17P2 1.6 
PE 34:4 1.949 710.472 710.4766 C39H70NO8P -6.5 
CL(70:4) -1.45 713.495 713.4945 C79H146O17P2 -0.7 
PE(34:1) 1.91 716.523 716.5236 C39H76NO8P -0.8 
PE(34:1) -1.988 716.525 716.5236 C39H76NO8P -2.0 
PE-Cer(d36:1) -3.028 723.518 723.5213 C38H77N2O6P 4.6 
CL(72:6) -1.469 725.495 725.4945 C81H146O17P2 -0.7 
CL(72:4) -2.552 727.508 727.5101 C81H150O17P2 2.9 
HexCer(d34:1) 3.823 734.534 734.5343 C40H77NO8Cl -0.4 
CL 74:8 -1.595 737.496 737.4945 C83H146O17P2 -2.0 
PS(P-34:2) or PS(O-
34:3) 
-1.629 742.505 742.5029 C40H74NO9P -2.8 
PS(O-34:2) or PS(P-
34:1) 
-1.92 744.52 744.5185 C40H76NO9P -2.0 
CL(76:9) -2.403 750.507 750.5023 C85H148O17P2 -6.3 






(Table 3.1 continued) 
 
     
PS(34:1) -2.779 760.515 760.5134 C40H76NO10P -2.1 
PE(38:5) 2.95 764.524 764.5236 C43H76NO8P 0.5 
PE(38:5) -3.097 764.525 764.5236 C43H76NO8P -1.8 
PS(O-36:5) or PS(P-
36:4) 
-2.89 766.505 766.5029 C42H74NO9P -2.7 
PS(O-36:3) or PS(P-
36:2) 
-1.487 770.536 770.5342 C42H78NO9P -2.3 
PE(P-40:7) -2.973 772.533 772.5287 C45H76NO7P -5.6 
PE(39:5) -1.826 778.539 778.5392 C44H78NO8P 0.3 
PE(O-40:5) or PE(P-
40:4) 
-1.684 778.574 778.5756 C45H82NO7P 2.1 
PE(38:4(OH)) -1.293 782.537 782.5342 C43H78NO9P -3.6 
PS(36:3) 2.314 784.514 784.5134 C42H76NO10P 0.8 
PS(36:3) -1.725 784.515 784.5134 C42H76NO10P -2.0 
PS(36:1) -1.525 788.54 788.5447 C42H80NO10P 6.0 
PS(36:1) 1.96 788.547 788.5447 C42H80NO10P 2.9 
PE(40:6) -2.732 790.541 790.5392 C45H78NO8P -2.3 
PE(40:5) -2.448 792.556 792.5549 C45H80NO8P -1.4 
PS(P-38:4) or PS(O-
38:5) 
-1.491 794.536 794.5342 C44H78NO9P -2.3 
PC(34:1) or PE(37:1) 1.965 794.548 794.5472 C42H82NO8PCl 1.0 
PS(37:1) 2.124 802.557 802.5604 C43H82NO10P -4.2 
PE(P-42:6) -2.323 802.572 802.5756 C47H82NO7P 4.5 
PE(40:6(OH)) -2.713 806.535 806.5342 C45H78NO9P -1.0 
PS(38:3) -1.489 812.545 812.5447 C44H80NO10P -0.4 
PS(38:3) 1.881 812.546 812.5447 C44H80NO10P 1.6 
PI-Cer(d34:0) -3.551 816.521 816.5163 C40H80NO11P -5.8 
PS(P-40:6) -3.376 818.538 818.5342 C46H78NO9P -4.6 
PG(40:7) -2.192 819.518 819.5182 C46H77O10P 0.2 
PS(40:7) -2.853 832.515 832.5134 C46H76NO10P -1.9 
PC(38:6) or PE(41:6) 2.579 840.53 840.5316 C46H80NO8PCl -1.9 
PC(38:4) or PE(41:4) 2.517 844.56 844.5629 C46H84NO8PCl -3.4 
PI(36:3) -1.486 859.534 859.5342 C45H81O13P 0.2 
PI(36:3) 1.939 859.534 859.5342 C45H81O13P -0.2 
PI(36:2) 3.072 861.55 861.5499 C45H83O13P 0.1 







3.3.3 DESI-IMS Ion Maps 
The strength of the IMS technology is the ability to evaluate the spatial 
distribution of metabolites in tissue. This perspective is particularly informative when 
examining neural tube closure, where cellular gene and metabolite profiles are rapidly 
changing in order for an early organism to expand and meet the spatiotemporal 
requirements of forming a neural plate and then folding into a tube (Smith and 
Schoenwolf, 1997). Because we observed defects in the cranial mesenchyme of Mthfd1l-
null embryos, the metabolomics of the mesenchymal tissue was particularly of interest, 
and IMS allowed not only for extraction of data corresponding to that region, but also 
chemical mapping of the tissue (Figure 3.4).  
Based on the metabolite map data, several qualitative observations can be made. 
The metabolites analyzed in these maps appear most concentrated in the mesenchyme 
and central regions of the cranial tissue. It seems that very little adenine or uracil was 
detected in the Mthfd1l-null samples, as well as a reduction in all of the essential amino 
acids that were measured by DESI-MS. L-methionine is lower in nullizygous cranial 
mesenchyme, which was expected due to its role downstream of mitochondrial formate in 
one-carbon metabolism. Based on ion maps of lactate, glucose, fumarate, citrate, and 
succinate, it seems that energy metabolism is dysregulated in the Mthfd1l-null samples 
compared to WT. Lastly, several ceramides were detected that SAM identified as 
significantly different, all of which were increased in abundance in Mthfd1l-null 
embryos. It is also important to note that succinate and citrate ion maps have significant 
amounts of background resulting from very low signal levels. These background values 












(Figure 3.4, continued on next page) 
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Figure 3.4. DESI-MS ion images of transverse sections of cranial embryonic tissue of 
Mthfd1l-null and WT embryos. Metabolites are organized from smallest m/z to 
largest, m/z value is displayed above each metabolite. Green arrows indicate 
metabolites selected by SAM analysis that are up-regulated in the mesenchyme of 
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null samples compared to WT, and blue arrows indicate metabolites selected by 
SAM analysis that are down-regulated in the mesenchyme of null samples 
compared to WT. Lack of an arrow indicates that this metabolite was not selected 
by SAM analysis as being significantly different between the mesenchyme-
containing regions of both groups (WT and null). Two representative embryo 
samples (rows) that display the range of metabolite concentrations observed 
within each group are shown for each metabolite (columns). H&E stains of tissue 
sectioned used in the DESI-IMS analysis displayed to the left of the visual spectra 
for each sample. Relative abundance is shown from 0 to 100%, from violet to red, 
respectively. 
3.3.4 PCA Analysis 
The hundreds of metabolites detected by DESI-MS were analyzed by PCA, and a 
clear separation between WT and Mthfd1l-null embryos was observed along component 3 
(Figure 3.5, A). When only metabolite data from the mesenchyme region was analyzed, 
the separation along component 1 was made more apparent as well (Figure 3.5, B). This 
method served to reveal trends between the two groups across all of the data obtained by 
DESI-MS, providing a clear picture of the grouping of data across different batches. In 
Figure 3.5 A, the batch effect was observed across component 1, when samples had lower 
PC1 values from an earlier run from both WT and Mthfd1l-null groups, and higher PC1 






Figure 3.5. PCA analysis of metabolites of Mthfd1l-null and WT embryos using 
median log normalization. Each data point is an embryo sample; nulls are 
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represented in green, and WT samples are in blue. Principle components (PCs) 1 
and 3 were considered in analyzing the data. PCA analysis was performed using 
R. (A) The PCA of spectra from the total embryo analyzed by IMS along 
components 1 and 3. (B) The PCA of the spectra from mesenchyme along 
components 1 and 3. 
3.3.5 T-test of Metabolites 
Differences in the relative abundance of metabolites in WT and Mthfd1l-null 
samples were analyzed by t-test, and p-values were adjusted for the false discovery rate 
(FDR) (Benjamini and Hochberg, 1995). The detected metabolites relevant to energy 
metabolism and amino acid metabolism compared by t-test are shown in Figure 3.6. 
Glucose, proline, uracil, and adenine levels in the Mthfd1l-null embryonic mesenchyme 
were significantly decreased. Ascorbic acid, lactate, glutamine, glutamate, and taurine did 
not vary much between groups nor across samples within each group. For citrate, 
fumarate, succinate, AMP, glutathione, and threonine, the means of the two groups 
appeared significantly different, yet SD values were too great for these metabolite 








Figure 3.6. Metabolomics analysis of cranial mesenchyme of Mthfd1l-/- embryos. 
Abundance of metabolites related to amino acid metabolism (top panel), nucleic 
acid metabolism (bottom left), and energy metabolism (bottom right) in Mthfd1l-/- 
embryos (green) relative to Mthfd1l+/+ embryos (blue). Data are shown with mean 
± SD. *, *** indicates       q < 0.05, and q < 0.0005, respectively. Calculated in 
Prism 8.  
∞Tentative attribution includes any of the following AMP species: 2'-
Deoxyguanosine 5'-monophosphate, 3'-AMP, Adenosine 2'-phosphate, 2-
































































































































































Removal of a key THF-interconverting enzyme from the one-carbon pathway is 
destined to disrupt metabolic homeostasis, and through evaluation of this disruption we 
come closer to understanding one-carbon metabolism. In particular, gene deletion during 
early development reflects even greater metabolic consequences due to the requirement 
of 1C units to meet the demands of a rapidly growing and changing cell population. The 
DESI-IMS platform used in this chapter provided high sensitivity in profiling molecules 
at specific locations in the early developing E8.75-9.5 mouse embryos, while still 
allowing for broad metabolite coverage. Using this non-targeted metabolomics approach, 
we were able to identify disruptions in amino acid, nucleic acid, and energy metabolism.  
Interestingly, the abundance of nearly all detected amino acids was decreased in 
the embryos lacking Mthfd1l. Based on IMS map images (Figure 3.4), proline, threonine, 
and glutamine all appeared to be diminished in the mesenchyme of the Mthfd1l-null 
samples. Further statistical analysis and FDR correction of all samples evaluated in this 
study reflected that only proline is significantly decreased in the nullizygous embryos 
(Figure 3.6). Maternal proline supplementation has been shown to increase growth and 
polyamine availability in porcine embryos (Wu et al., 2008). A decreased supply of 
amino acids could have deleterious effects on protein synthesis in the developing embryo, 
especially during neural tube closure, when rapid growth and cell division are occurring. 
These findings are consistent with whole embryo LC-MS metabolomics done previously 
by our lab, although the data from the whole embryo lysates reflected significant 
increases in aspartate and taurine in the null samples  (Bryant et al., 2018). This 
discrepancy is likely a result of the difference in biosynthetic demands across tissue 
types. A decrease in amino acid abundance was also reported in the NTD-prone Lrp6-/- 






range of amino acids than just serine and glycine is intriguing, and further studies on how 
one-carbon metabolism impacts amino acid synthesis should be considered. Furthermore, 
maternal proline supplementation in our mouse model, possibly in combination with 
formate, may partially rescue the growth defects characteristic of Mthfd1l-null embryos. 
Compared to WT embryos, energy metabolism was disrupted in the mesenchyme 
of embryos lacking Mthfd1l. Glucose was significantly diminished (Figure 3.6), and the 
IMS maps (Figure 3.4) indicate very little to no signal in the mesenchyme. Although they 
do not reach statistical significance following FDR correction, both citrate and fumarate 
are increased slightly in the Mthfd1l-null embryos, suggesting an increase in flux through 
the tricarboxylic acid (TCA) cycle. Because healthy E9.5 embryos exhibit increased 
contributions from glycolysis during chorioallantoic branching (Miyazawa et al., 2017), 
deletion of Mthfd1l may reduce lactate production and shift energy metabolism towards 
the more efficient TCA cycle. This is supported by earlier MS studies indicating that 
Mthfd1l-null embryos have decreased lactate abundance (Bryant et al., 2018). In my 
study, lactate was identified by SAM analysis as being significantly decreased in the null 
samples (Figure 3.3, 3.4). Pyruvate was not detected by DESI-IMS, likely due to its small 
size, but it would be interesting to observe pyruvate distribution in cranial mesenchyme 
tissue using MALDI-IMS, in order to more clearly evaluate rewiring of glucose 
metabolism that may occur in embryos lacking Mthfd1l. Whereas the best resolution 
offered by DESI is approximately 100µm, MALDI is capable of reaching 10µm 
resolution (Touboul and Brunelle, 2016). MALDI would also be able to detect smaller 
metabolites involved in one-carbon metabolism such as formate, which would be very 
informative in our understanding of how formate is processed in the developing Mthfd1l-






Another reason formate (m/z = 45) was not detected in this study is a result of the 
m/z range readable by the Orbitrap mass analyzer, which can only detect m/z ≥ 50. In 
future studies, a mass analyzer with a lower m/z range should be utilized so that formate 
might be detected and analyzed. A further challenge with formate detection arises from 
the presence of CO2 in the sample, as the mass is so similar to formate (44g/mol and 
45g/mol, respectively) that the two signals overlap. 
The vast majority of 1C units used to synthesize purines, thymidylate, and 
AdoMet in the cytoplasm are first oxidized in the mitochondria (Yoshida and Kikuchi, 
1971; Barlowe and Appling, 1988). Without Mthfd1l, these oxidized 1C units won’t be 
released from the mitochondria as formate, and intercellular pools of purines, 
thymidylate, and AdoMet should decrease. Our findings in this study confirmed this 
hypothesis. Of nucleotide species, DESI-IMS detected adenine and AMP, as well as a 
number of thymidylate derivatives, including uridine, uracil, deoxyuridine, and 
ribothymidine. Every one of these metabolies were decreased in the mesenchyme of 
Mthfd1l-null embryos (Figure 3.4, 3.6). It is likely that reduced flux of formate into the 
cytoplasm inhibits normal purine synthesis, and any free intracellular adenine (or 
guanine) will likely be used to synthesize DNA. Cytoplasmic 1C units that are not used 
for purine or thymidylate synthesis are reduced to 5-methyl THF for the synthesis of 
methionine, which was also reduced in embryos lacking Mthfd1l.  
Although SAM analysis identified 516 molecular ions that were significantly 
different between the two groups, we were unable to assign all of the ions selected 
because there were no potential matches in the Human Metabolome Database (HMDB) 
or Lipidmaps database with a mass error of less than 10ppm. Of those that we were able 
to assign, we further processed with MS/MS in order to confirm by fragmentation 






difficult to isolate all of the identified molecules using DESI-MS/MS. In the future, we 
propose running a lipid extraction prior to MS/MS in order to more competently isolate 
ions.  
The number of ions selected by SAM analysis as significantly increased or 
decreased in null samples suggests that deletion of Mthfd1l leads to an overall reduction 
in abundance of metabolites. Of 516 significantly different ions, 437 were decreased in 
Mthfd1l-null embryos, leaving only 79 metabolites that increased in abundance compared 
to WT. It is likely that the absence of mitochondrially-derived formate slows flux through 
the cytoplasmic 1C biosynthetic reactions of purine and thymidylate synthesis, as well as 
methionine synthesis, which remethylates AdoHcy to produce AdoMet in the methyl 
cycle. Further analysis of AICAR, FAICAR, fluorouracil, phosphoribosyl pyrophosphate, 
and other intermediates involved in purine and thymidylate synthesis using MALDI-MS 
and/or NMR methods is needed to elucidate the mechanism at work when Mthfd1l is 

















CHAPTER 4: CHARACTERIZATION OF EMBRYONIC MICE 
LACKING MITOCHONDRIAL FORMATE-PRODUCING 
ENZYMES MTHFD1L AND ALDH1L2 
 
4.1 INTRODUCTION 
Formate is a smaller and more mobile carrier of 1C units than THF-bound 
metabolites, as evidenced by the greater concentration of formate in blood than folates.  
Approximately 50% of the formate found in serum is produced via a folate-dependent 
mechanism in the mitochondria, as it is the final product of the 10-formyl-THF 
synthetase reaction catalyzed by MTHFD1L (Meiser et al., 2016). Formate is also 
produced via folate-independent mechanisms in the cytoplasm, from the catabolism of 
tryptophan and choline, the synthesis of cholesterol and sterol, the oxidation of 
formaldehyde, peroxisomal α-oxidation of phytanic acid, and lastly in the endoplasmic 
reticulum, by a number of different cytochrome-P450-catalyzed demethylation reactions 
(Figure 4.1, reviewed in Brosnan and Brosnan, 2016). The endogenous pool of formate in 
an organism is further increased by contributions from the intestinal microbiome. In the 
gut, formate (along with acetyl CoA) is a fermentation product of anaerobic bacteria, and 








Figure 4.1. Intercellular sources of formate. Figure from (Brosnan and Brosnan, 2016). 
As mentioned previously, formate supplementation during pregnancy has been 
proven to reduce the incidence of NTDs caused by defects in 1C metabolism in mice 
(Momb et al., 2013; Narisawa et al., 2012; Pai et al., 2015). The requirement for 
mitochondrially derived formate during embryonic development was demonstrated by 
our lab’s Mthfd1l-null mouse model, as formate supplementation via maternal drinking 
water was not able to completely prevent birth defects (Momb et al., 2013). Based on 
what is currently known, Mthfd1l is the sole enzyme responsible for formate production 






Mthfd1l-null embryos continue to produce formate—which they do at approximately 1/3 
the amount produced by mitochondria from WT embryos (Bryant et al., 2018). The 
tracing experiment that identified this residual formate production measured the 
conversion of L-[3-14C]-serine to [14C]-formate, thereby suggesting the existence of an 
additional formate-producing mitochondrial pathway from the 3-carbon of serine. It is 
important to note that the amount of formate produced by Mthfd1l-null mitochondria in 
vivo is still insufficient to support embryonic development, as demonstrated by the 100% 
penetrance of birth defects and reduction in methionine production in Mthfd1l-null 
embryos (Momb et al., 2013; Bryant et al., 2018).  
This chapter is focused on better understanding additional sources of formate 
resulting from serine oxidation in the mitochondria. As described in Chapter 1.4, Aldh1l2 
is the mitochondrial 10-formyl-THF dehydrogenase that catalyzes the formation of CO2 
and THF from 10-formyl-THF in an NADP+ dependent manner. Because Aldh1l2 has 
been shown to produce formate in vitro, it is possible that this enzyme is responsible for 
mitochondrial 10-formyl-THF dehydrogenase activity as well (Krupenko et al., 2010; 
Strickland et al., 2011a). As confirmed with immunoblotting, Aldh1l2 was shown to be 
highly expressed in both WT and Mthfd1l-null mitochondria that continue to produce 
formate in organello (Bryant et al., 2018). Because the specific metabolic processes 
underlying NTDs are not understood, the generation of a mouse line that lacks the 
mitochondrial 1C pathway enzymes Aldh1l2 and Mthfd1l will help elucidate the source 
and role of mitochondrially produced formate during development.   
 







4.2 MATERIALS AND METHODS  
4.2.1 Mthfd1lz/z/Aldh1l2-/- Mouse Model Design 
This study used protocols approved by the Institutional Animal Care and Use 
Committee of the University of Texas at Austin, and care of animals was performed in 
accordance with the guidelines approved by the National Institutes of Health for the Care 
and Use of Laboratory Animals. All mice were maintained on a C57BL/6 genetic 
background, exposed to a 12-hour light/dark cycle, and fed commercially available 
laboratory chow (LabDiet 5K67).  
Aldh1l2-/- mice were a generous gift from the Krupenko lab (University of North 
Carolina Nutrition Research Institute), and were produced at the Medical University of 
South Carolina (MUSC) Transgenic Models Facility using embryonic stem cells with a 
targeted knockout of Aldh1l2 purchased from the Knockout Mouse Program (KOMP) 
resource. These ESCs were generated by insertion of the target sequence by homologous 
recombination, and injected into Albino B6 blastocysts. These embryos were then 
injected into pseudo-pregnant mice. Male chimeras born from injected blastocysts were 
bred to Albino B6 females to obtain heterozygous Aldh1l2+/- mice with one targeted 
allele (germline transmission). These heterozygous mice were interbred to produce the 
Aldh1l2-/- mouse line (Krupenko, unpublished).  
 Heterozygous Mthfd1lz/+ mice were generated as explained in Chapter 2.2.1. 
Mthfd1lz/+ and Aldh1l2-/- mice were crossed to yield Mthfd1lz/+ / Aldh1l2+/- mice, which 






the desired double knock-out Mthfd1lz/z / Aldh1l2-/- embryo model. 
 
 
4.2.2 Mthfd1lz/z/Aldh1l2-/- Mouse Model Genotyping 
 Mice were genotyped for Mthfd1l as described in Chapter 2.2.2. For Aldh1l2, the 
same genotyping protocol was utilized (Stratman et al., 2003). A set of primers was used 
to amplify a 338 bp region of DNA in the wild type allele. In the forward direction, 5’-
AATTGGTGGTTCTCTCAAGTCTG was used, and in the reverse, 5’-
GCACCCATAAAGGGGCTCAAG was used. In the mutant allele, an amplicon 598 bp 
was produced from forward primer 5’-CACACCTCCCCCTGAACCTGAAA and reverse 
primer 5’-GACATATACTGACCTCTGAGGGTGGC. 
4.2.3 Embryo Collection 
 Embryos were collected as outlined in Chapter 2.2.3. 
4.2.4 Histology 
 Histology was performed as outlined in Chapter 2.2.4. 
4.2.5 Alcian Blue Staining 
 Alcian blue staining was performed as outlined in Chapter 2.2.6. 
4.2.6 Isolation of Mitochondria from Adult Mouse Liver 
The morning of the mitochondrial isolation, 3 month old mice were euthanized by 
CO2 asphyxiation and livers were removed and rinsed in ice cold 1X PBS.  For each 
mouse 0.5 g of liver was added to 5mL homogenization medium (0.3 M sucrose, 1 mM 






Cells were disrupted using a glass-teflon Thomas homogenizer attached to a drill press 
operating at 87-rpm. For each sample, 10 up-and-down strokes were used to homogenize 
the cells in the mixture. The homogenate was diluted to 18mL, and centrifuged for 15 
minutes at 660 X g in a Sorval RC5C SS-34 rotor at 4°C to pellet out cell debris. The 
supernatant was carefully removed and spun at 7,700 X g for 15 minutes to pellet the 
mitochondria. For samples to be analyzed by Western blot, the pellet was resuspended in 
1mL 0.1% NP-40 buffer (0.1% Nonidet P-40, 100 mM Tris, pH 7.5, 150 mM NaCl) that 
contained a Pierce protease inhibitor tablet (ThermoFisher).  (Pike et al., 2010; Bryant et 
al., 2018) 
4.2.7 Bradford Assay 
 Bradford Dye Reagent (Bio-Rad) absorbance was measured at 595 nm, a standard 
curve was created from a range of BSA concentrations (0, 5, 10, 20 µg/L) that was used 
to determine concentration of mitochondrial protein extracts.  
4.2.8 Western Blot Analysis 
 Mitochondrial extracts in 0.1% NP-40 buffer were standardized using 
concentration levels determined by the Bradford Assay. For each sample, mitochondrial 
lysate was added to SDS-PAGE loading buffer and boiled at 90ºC before analysis by 
SDS-PAGE. Each well contained 200 µg of mitochondrial protein (Pike et al., 2010). 
4.2.9 Maternal Supplementation with Calcium Formate 
Formate supplementation was achieved by the addition of calcium formate to the 
drinking water of Mthfd1lz/+ mating pairs. Concentration of calcium formate was 0.1 M to 






25 g C57BL/6 mouse (Momb et al., 2013). 
4.2.10 Fertility Analysis in Male Mice 
Testis, vas deferens and epididymis were dissected from both Mthfd1l+/+/ 
Aldh1l2+/+ (WT) and Mthfd1lz/+/ Aldh1l2-/- males. Testis were imaged using a Leica M80 
stereomicroscope and Leica IC80 camera.  Testis, vas deferens and epididymis were 
minced and placed in HTF medium for 5 minutes at 55ºC to release sperm, which were 
also imaged with the Leica stereomicroscope and camera. 
4.3 RESULTS 
4.3.1 Phenotype Analysis of Mthfd1l and Aldh1l2 Mutant Mice 
4.3.1.1 Breeding Phenotype 
Mthfd1lz/+ and Aldh1l2-/- mouse lines were crossed and bred for three generations 
in order to generate Mthfd1lz/z/ Aldh1l2-/- embryos for analysis (Figure 4.2).  Timed 
matings were set up between Mthfd1lz/+/ Aldh1l2-/- mice in order to collect embryos at 
E10.5 for embryonic phenotype analysis, however only 5 of 32 (15.6%) females that 
were plugged were actually pregnant at E10.5 (Table 4.1). In comparison, 35 of 40 
(87.5%) Mthfd1lz/+/ Aldh1l2+/+ plugged female mice were pregnant at E10.5. Litter sizes 
of Mthfd1lz/+/ Aldh1l2-/- mice were comparable in size to those born to Mthfd1lz/+/ 
Aldh1l2+/+ mice.  
To examine the reduced fertility phenotype of Mthfd1lz/+/ Aldh1l2-/- mice, I mated 
Mthfd1lz/+/ Aldh1l2-/- males with Mthfd1l+/+/ Aldh1l2+/+ (WT) females, as well as WT 
males with Mthfd1lz/+/ Aldh1l2-/- females. Over 10 months, these mating pairs failed to 
become pregnant.  
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Figure 4.2. Breeding scheme of Mthfd1lz/+ x Aldh1l2-/- mice to generate Mthfd1lz/z / 
Aldh1l2-/- compound KO mouse line. Genotyping of both gene constructs is 
shown to the lower left.  Embryos were to be analyzed in this study because the 






Table 4.1: Litter size and fertility of Mthfd1lz/+/ Aldh1l2-/- breeding pairs. All 
pregnant females were dissected at E10.5 for embryo analysis. Fertility rate 
is calculated as number of litters divided by number of inseminated females 
(as determined by observation of vaginal plug at E0.5). Average litter size is 









Mthfd1l	z/+	 40	 35	 87.5%	 9.1±1.6	

























4.3.1.2 Embryonic Phenotype 
 Due to the dramatically reduced fertility of Mthfd1lz/+/ Aldh1l2-/- mice, only 5 
litters were alive at E10.5, the time of dissection of mothers that were determined to be 
pregnant, based on the observation of a conspicuous vaginal plug. Analysis of this limited 
number of Mthfd1lz/z/ Aldh1l2-/- embryos revealed that 100% of the Mthfd1l-null, 
Aldh1l2-null embryos exhibited an open neural tube and severely stunted growth (Figure 
4.3). When compared to Mthfd1l-null embryos alone, the double KO embryos had 
reduced crown-rump (CR) length, reduced overall body size, and were slightly more 
transparent. Because the y-intercepts of the trendlines of somite number versus CR length 
for each embryonic genotype group are not statistically significantly different (p > 0.05), 
the relationship between growth and developmental progression does not appear to be 








Figure 4.3. Gross morphology of Mthfd1l/Aldh1l2 breeding embryos at E10.5. 
Matched littermates were imaged at 28X from breeding crosses with Mthfd1lz/+ 
mice (top row) and Mthfd1lz/+/Aldh1l2-/- mice (bottom row). Scalebar shown is 
500µm. Deletion of both Mthfd1l and Aldh1l2 results in an embryo with severely 












Figure 4.4. Growth and developmental progression in Mthfd1l/Aldh1l2 mutant 
embryos. Growth is measured by crown-rump length, in centimeters, and 
developmental progression is measured by somite number of embryos. The 
relationship between growth and developmental progression does not appear to be 
disrupted in Mthfd1lz/z/ Aldh1l2-/- embryos (p>0.05). ( , Mthfd1l+/+ / Aldh1l2-/-; 
, Mthfd1lz/+ / Aldh1l2-/-; , Mthfd1lz/z / Aldh1l2-/- embryos) 
 
4.3.1.3 Adult Phenotype 
Because Mthfd1l deletion is incompatible with life, Mthfd1lz/z/Aldh1l2-/- mice do 
not survive to full term. However, the ≥ 8 week old Mthfd1lz/+/Aldh1l2-/- mice used to 
breed Mthfd1lz/z/Aldh1l2-/- embryos did present a phenotype (Figures 4.5 and 4.6). 
Neither Mthfd1lz/+ nor Aldh1l2-/- mice show any observable phenotype, but mice 
with a combined Mthfd1lz/+/Aldh1l2-/- background do present a phenotype. These mice 
occasionally have congenital hydrocephaly and/or anophthalmia (lacking one or both 
eyes). Additionally, after 8 weeks of age, some display stunted growth and many have 
extremely low fertility rates.  
 
 






























Figure 4.5. Observed phenotypes of adult mice with the genotype Mthfd1lz/+/Aldh1l2-
/- born from Mthfd1lz/+/Aldh1l2+/- breeding pairs. Some mice, both male and 
female, were born with anophthalmia in one or both eyes (6), some were born 






Figure 4.6. Mthfd1lz/+/Aldh1l2-/- mice occasionally display hydrocephalus and 
anopthalmia phenotype. Image of healthy Mthfd1l+/+/Aldh1l2+/+ mouse (left) and 
image of mouse with Mthfd1lz/+/Aldh1l2-/- genotype (right). Both mice pictured at 






4.3.2 Analysis of Mthfd1l and Aldh1l2 Expression Across Different Mouse Lines 
 Adult liver lysates from mice with different genotypes were evaluated for Mthfd1l 
and Aldh1l2 protein expression (Figure 4.7).  The purpose of this experiment was to 
determine if the observed phenotype of reduced fertility in Mthfd1lz/+/Aldh1l2-/- mice was 
associated with varying levels of Mthfd1l expression across individual mice of this 
genotype. Expression levels of both Mthfd1l and Aldh1l2 are inconsistent within a single 
genotype. For example, among Aldh1l2+/+ mice, Aldh1l2 expression varies across 
individuals. As expected, there was reduced expression of Mthfd1l and Aldh1l2 in mice 






















Mthfd1l          +/+   +/+     z/+       z/+         z/+        z/+          z/+    
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Figure 4.7. Western blot analysis of Mthfd1l and Aldh1l2 expression in individual 
adult mouse livers of different genotypes. Upper panel: Lane 1 contains 
mitochondrial lysate from a mouse with a WT background, lane 2 from 
Mthfd1l+/+/Aldh1l2-/-, lanes 3-5, from Mthfd1lz/+/Aldh1l2+/+, lane 6 from 
Mthfd1l+/+/Aldh1l2+/-, and lane 7 from Mthfd1lz/+/Aldh1l2-/-. Mitochondria were 
isolated from maternal livers, and a western blot of standardized total 
mitochondrial protein extracts was analyzed by SDS-PAGE electrophoresis. Each 
lane was loaded with 200 µg protein due to the low expression levels of Mthfd1l 
in adult mice. Immunoblots were probed with antibodies against Mthfd1l (100 
kDa), Aldh1l2 (100kDa), and the mitochondrial matrix protein Hsp60 (60 kDa) as 
a loading control. Lower Panel: Densitometry of the expression of Mthfd1l and 
Aldh1l2 in upper panel normalized to the Hsp60 signal. Genotype of mice used in 


























































































4.3.3 Formate Supplementation Fails to Rescue NTDs caused by Mthfd1l and 
Aldh1l2 Deletion 
 Because formate supplementation has been shown to partially rescue the NTD 
and growth defect in Mthfd1lz/z embryos, the Mthfd1lz/z/Aldh1l2-/- embryos were also 
supplemented to evaluate if partial rescue was possible. Pregnant mothers were 
supplemented with calcium formate at a dose of 2,500 mg/kg/day in the drinking water. 
The reduced fertility of Mthfd1lz/+/Aldh1l2-/- adult mice was not improved with formate 
supplementation, and of 12 supplemented pregnant mothers, only 2 litters were present at 
E10.5, when mothers were dissected. Although this study is extremely limited in sample 
size, calcium formate supplementation did not rescue the NTDs or growth defects of 







Figure 4.8. Formate supplementation of Mthfd1lz/z/Aldh1l2-/- embryos does not rescue 
growth defect phenotype as significantly as it does Mthfd1lz/z mice. Embryos 
imaged at E10.5. In the top panel, the supplementation of calcium formate at a 
dose of 2,500 mg/kg/day in maternal drinking water partially rescues the growth 
defect in Mthfd1lz/z embryos (experiment done by Dr. Jessica Momb), but the 










4.3.4 Deletion of Mthfd1l and Aldh1l2 Disrupts Embryonic Tissue Organization  
 Like in Chapter 2.3.2, the histology of Mthfd1lz/z/Aldh1l2-/- embryos were 
evaluated by H&E stains of paraffin sections. The cranial tissue of Mthfd1lz/z/Aldh1l2-/- 
embryos appeared disordered and cell shape was dysmorphic, unlike the round and 
evenly distributed cells observed in WT embryos (Figure 4.9). This observation was 
consistent from transverse sections starting in the cranial regions to the branchial arches. 
The sample population for this experiment was n=1 WT, with multiple technical 
replicates throughout the embryo, and n=2 Mthfd1lz/z/Aldh1l2-/-, also with multiple 




















Figure 4.9. Deletion of Mthfd1l and Aldh1l2 result in disrupted cell structure and 
tissue organization. H&E stains of paraffin embedded E10.5 embryo sections 
along the transverse plane in the cranial region (top panel) and through the 














4.3.5 Deletion of Mthfd1l and Aldh1l2 Disrupts Extracellular Matrix Structure 
 Hyaluronic acid (HA) has been shown to influence mesenchyme cell fate, 
proliferation, adhesion, and morphology, which are all important during neural tube 
closure (Chen et al., 2007; Knudson, 2003; Morris-Wiman and Brinkley, 1990a; Nilsson 
et al., 2003; Peck and Isacke, 1996). As with the Mthfd1lz/z embryo analysis in Figure 2.5, 
Mthfd1lz/z/Aldh1l2-/- embryos were evaluated for HA composition within the ECM. 
Littermate embryos dissected at E10.5 were paraffin embedded, sectioned, and stained 
with Alcian blue to detect HA and evaluate the integrity of the ECM, and determine if it 
is more poorly structured than in the Mthfd1lz/z embryo. Mthfd1lz/z/Aldh1l2-/- embryos not 
only display sparse distribution of mesenchyme, but HA is not evenly distributed 
throughout the ECM, causing cell clusters and poor adhesion and matrix formation 
between mesenchyme cells. This experiment was done with a sample size of n=2 




Figure 4.10. Mthfd1lz/z /Aldh1l2-/- embryos have a disruption in HA distribution in the 
ECM. Alcian blue staining of paraffin embedded sections at E10.5 of WT (left) 
and Mthfd1lz/z /Aldh1l2-/- (right) mouse embryos. Nuclear fast red was used as a 






4.3.6 Males with Mthfd1lz/+/Aldh1l2-/- Genotype Exhibit Healthy Testes and Sperm 
 Because adult Mthfd1lz/+/Aldh1l2-/- mice exhibit reduced fertility, the testis and 
sperm cells of Mthfd1lz/+/Aldh1l2-/- males was examined for any observable phenotype. 
The testes of 6-month-old WT and Mthfd1lz/+/Aldh1l2-/- mice appeared to be 
approximately the same size, and no overall significant difference was observed. Mice 
dissected for analysis had been mated previously with female mice of the same age. 
 Similarly, the sperm of both groups were robust and motile, indicating that the 
lack of fertility was not caused by unhealthy nor insufficient sperm production in 













Figure 4.11. Mthfd1lz/+/ Aldh1l2-/- adult males appear to be fertile with healthy testes 
and sperm. Top panel: Testis of WT (left) and Mthfd1lz/+/ Aldh1l2-/- (right) males. 
Bottom panel: Sperm of WT (left) and Mthfd1lz/+/ Aldh1l2-/- (right) males. Both 
cell populations appeared robust and motile, indicating that the Mthfd1lz/+/ 







This study was designed to examine if Aldh1l2 serves as a source of formate in 
vivo, and also to further explore the importance of formate during neurulation. Due to the 
observed phenotype of reduced fertility in the parental F1 generation, we were unable to 
collect a sufficient number of embryo samples to confirm with confidence the 
developmental consequences of a Mthfd1lz/z/Aldh1l2-/- mutant mouse. This chapter is a 
reflection of the work completed on this mouse model, however these experiments will 
need to be repeated to generate essential statistical support of a larger sample size.  
From the limited number of available embryos, we observed that 
Mthfd1lz/z/Aldh1l2-/- embryos were further reduced in size compared with Mthfd1lz/z 
embryos (Figure 4.3), and were not responsive to maternal formate supplementation 
(Figure 4.8). It is possible that in the Mthfd1lz/z embryo, the formate produced by Aldh1l2 
in combination with 2,500 mg/kg sodium formate daily in maternal drinking water is 
sufficient to partially improve the growth defects that occur without supplementation. If 
this is the case, then Mthfd1lz/z/Aldh1l2-/- embryos may not have enough basal formate 
production to respond to exogenous maternally-sourced formate. In the future, 
experiments using labeled formate in maternal drinking water are warranted in order to 
examine the fate of maternal formate in the embryo. 
Histological analysis revealed cellular disorganization in the neural tissue of 
E10.5 embryos lacking Mthfd1l and Aldh1l2 (Figure 4.9). This embryonic phenotype 
was similar to that of Cbp-/- embryos, which lack a gene associated with pattern 
formation and exhibit exencephaly, defective NTC, and reduced density of 
neuroepithelium (Tanaka et al., 2000). Cbp-/- mice die between E10.5-12.5 due to 






what caused the observed defects in Mthfd1lz/z/Aldh1l2-/- embryos, it may be informative 
to examine haematopoiesis in this mouse in the future. 
A recent experiment suggests that respiring mitochondria lacking Mthfd1l 
expression continue to produce formate, and evidence an increase in Aldh1l2 expression 
(Copp and Greene, 2013). In order to test our hypothesis that the measured formate was a 
product of the Aldh1l2 hydrolase reaction, we planned to repeat the serine oxidation 
assay using isolated respiring mitochondria from Mthfd1lz/z/Aldh1l2-/- embryos. This 
experiment requires a substantial amount of embryos in order to isolate enough 
mitochondria to generate a detectable quantity of formate. Unfortunately, the reduced 
fertility in the Mthfd1lz/+/Aldh1l2-/-  parent generation prevented sufficient collection of 
embryos which was necessary to realize the assay at this time. It will be necessary to 
carry out this experiment in the future in order to test the hypothesis that Aldh1l2 is a 
source of mitochondrial formate during development. Because maternal formate 
supplementation failed to prevent the infertility issue, additional approaches to enhance 
fertility may be successful. It has been shown that maternal diets supplemented with 
omega 3-fatty acids improves egg health (Nehra et al., 2012), therefore possible dietary 
supplementation may enhance fertility in Mthfd1lz/+/Aldh1l2-/- females. In this study, the 
fertility of Mthfd1lz/+/Aldh1l2-/- males were examined to reveal healthy spermatogenesis, 
as sperm count and motility was indistinguishable from WT sperm (Figure 4.11). The 
fertility of both Mthfd1lz/+/Aldh1l2-/- males and females was further investigated by cross-
mating adults with their WT counterparts, yet these breeding pairs also did not become 
pregnant.  
To our knowledge, there are no examples of mice mutant for one-carbon pathway 
genes that evidence only a reduction in fertility. It is unclear what may have caused this 






decreases during times of stress (Castelhano-Carlos and Baumans, 2009). Given that the 
Mthfd1lz/+ mice are from a C57BL/6N substrain mouse, and the Aldh1l2-/- mice are from a 
C57BL/6J substrain, it may be that one or a combination of both leads to an increase in 
sensitivity to stress.  
In addition to the challenges of reduced fertility, adult Mthfd1lz/+/Aldh1l2-/- mice 
also evidenced an abnormally high instance of hydrocephalus—10 out of 72 total adults. 
In C57BL/6 mice, the reported hereditary rate of hydrocephalus is 1-4% (Sundberg et 
al.), however we found that to be the case for 13.89% of Mthfd1lz/+/Aldh1l2-/- mice in this 
study. Hydrocephalus is often associated with NTDs (Copp and Greene, 2013), therefore 
it was considered that mice with mutations in both Mthfd1l and Aldh1l2 may have NTDs 
or delayed NTC. The expression of Mthfd1l and Aldh1l2 of Mthfd1lz/+/Aldh1l2-/- mice 
were investigated (Figure 4.7), and mice heterozygous for either gene displayed variable 
expression levels: between 7.8 and 47.9% that of WT. It is possible that in some cases, 
expression levels were low enough to reduce overall catalytic activity and disrupt healthy 
development. Further protein expression assays will be required to make any conclusions 
about the cause of hydrocephalus, anophthalmia, and reduced fertility in 
Mthfd1lz/+/Aldh1l2-/- mice. Although the relationship between Aldh1l2 and formate 
metabolism during development remains unclear, the embryonic and adult phenotypes 









CHAPTER 5: SUMMARY, CONCLUSIONS, AND FUTURE 
DIRECTIONS 
5.1 SUMMARY 
Mthfd1l is the only known mitochondrial enzyme that catalyzes the production of 
formate from 10-formyl THF (Prasannan et al., 2003). This formate is used in purine and 
thymidylate synthesis, and accounts for at least 75% of the 1C units that enter the methyl 
cycle (Pike et al., 2010). The work presented in this dissertation is focused on 
understanding how mitochondrially-derived formate supports healthy neurulation, and 
exploring additional sources of mitochondrial formate. Paraffin sectioning of Mthfd1l-
null mouse embryos revealed reduced density in cranial mesenchyme and dysregulated 
extracellular matrix (ECM) formation. The ECM component hyaluronic acid (HA) is 
associated with proper neural fold elevation (Morris-Wiman and Brinkley, 1990a). HA 
was found to be decreased in abundance in null embryos. Similarly, expression of 
basement membrane protein Collagen IV was reduced in embryos lacking Mthfd1l. 
Imaging mass spectrometry (IMS) suggested that decreased purine, thymidylate, and 
amino acid synthesis occurs in Mthfd1l-null cranial mesenchyme, as well as altered 
energy metabolism. Residual production of formate from Mthfd1l-null mitochondria 
suggests that Aldh1l2 may contribute to formate synthesis in the mitochondria (Figure 
5.1) (Bryant et al., 2018). A Mthfd1l/Aldh1l2 double KO mouse line was constructed to 
test this hypothesis. Mouse embryos null for both genes exhibited dramatic defects in 













Figure 5.1. Hypothetical model of formate production in the mitochondria. Deletion 
of Mthfd11l reduces formate production and flux through folate-dependent 
one-carbon metabolism, yet mitochondria from Mthfd1l-null mouse 
embryos still produce formate (Bryant et al., 2018). Mitochondrially-derived 
formate enters the cytoplasm and fuels the production of purines, 
thymidylate (dTMP), and methyl groups via AdoMet. Grey ovals represent 








5.2 CONCLUSIONS AND FUTURE DIRECTIONS 
Deletion of Mthfd1l causes dysregulated mesenchyme development (Shin, 2016), 
and my work described in Chapter 2 focused on understanding the origin of these defects. 
The reduced density of cranial mesenchyme cells in Mthfd1lz/z embryos prior to NTC was 
confirmed with classical histological analysis of paraffin-embedded tissue. Alcian blue 
staining reflected defects in glycosaminoglycan (GAG) formation, which suggests that 
the ECM does not form properly in embryos without Mthfd1l expression. Because the 
ECM influences mesenchyme formation (Assis-Ribas et al., 2018; Gattazzo et al., 2014; 
Hall and Watt, 1989; Wang and Chen, 2013; Watt and Huck, 2013), I hypothesized that 
the poorly formed mesenchyme evident in Mthfd1lz/z embryos was associated with 
dysregulated ECM development. This hypothesis was investigated using 
immunohistochemistry to evaluate the integrity of the ECM in embryonic cranial tissue 
lacking Mthfd1l, and Collagen IV expression was found to be significantly reduced. 
Fibronectin expression was also examined, and was not altered in Mthfd1lz/z embryos. 
Continued work is needed in order to understand this association between ECM proteins 
and mesenchyme formation in Mthfd1lz/z mice. I am currently studying the expression of 
Collagen I and Laminin α5 in embryos to better understand how Mthfd1l deletion impacts 
ECM formation during development.  
I complimented my evaluation of cranial tissue formation with non-targeted 
metabolomics analysis of Mthfd1lz/z embryos in the regions where mesenchyme defects 
were observed. We collaborated with the Eberlin research group to perform DESI-IMS 
on these embryos, and analyzed significant differences in metabolite abundance between 
WT and Mthfd1l-null embryos. We determined that Mthfd1l deletion led to reduced 
abundance in purine and thymidylate derivatives in the cranial mesenchyme tissue, as 






dysregulated energy metabolism. Further work that utilizes the high resolution of 
MALDI-IMS will be needed in order to evaluate formate distribution and abundance in 
the cranial mesenchyme of Mthfd1lz/z embryos. The use of IMS to correlate tissue 
formation and metabolism provides a direct link between biochemistry and development. 
In turn, continued application of this approach using additional developmental mutant 
models will expand our current understanding of the role of metabolism during 
development.  
Because Mthfd1l is a mitochondrial protein that encourages both metabolic 
homeostasis and healthy tissue formation, it is also a possibility that mitochondria lacking 
Mthfd1l are not properly formed. Work is currently underway to evaluate the state of 
mitochondria in Mthfd1lz/z embryos using electron microscopy.  
Mitochondria derived from Mthfd1l-null embryos continue to produce a small 
amount of formate and exhibit an increase in Aldh1l2 expression (Bryant et al., 2018). I 
explored the hypothesis that Aldh1l2, which can produce formate in vitro (Krupenko et 
al., 2010), is responsible for the formate synthesis we observe in Mthfd1lz/z embryos. I did 
this by breeding mice null for both Mthfd1l and Aldh1l2, which hypothetically lack 
mitochondrial production of formate. A breeding phenotype of reduced fertility in the 
parental Mthfd1lz/+ /Aldh1l2-/- generation prevented my collection of a sufficient number 
of embryo samples. Of the Mthfd1lz/z /Aldh1l2-/- embryos I was able to collect, I observed 
more dramatic growth defects than those of Mthfd1lz/z embryos. Additionally, formate 
supplementation did not rescue the phenotype as significantly as it does Mthfd1lz/z 
embryos. Lastly, both mesenchyme tissue formation and ECM composition appeared 
dysregulated in Mthfd1lz/z /Aldh1l2-/- embryos. More studies of this double KO mouse 
model are needed in order to repeat my work and confirm my observations, which can be 






experiment should be performed in mitochondria isolated from Mthfd1lz/z/Aldh1l2-/- 
embryos, because if Aldh1l2 is responsible for redundant mitochondrial formate 


























Appendix I: List of Acronyms 
 
1C: One-carbon 
AICAR: Aminoimidazole carboxamide ribonucleotide  
ALDH1L1: Cytoplasmic 10-CHO-THF dehydrogenase  
ALDH1L2: Mitochondrial 10-CHO-THF dehydrogenase  
AMT: Aminotransferase 
BHMT: Betaine hydroxymethyltransferase  
CDC: Centers for disease control and prevention 
CNS: Central nervous system 
CR: Crown-rump 
cSHMT: Cytoplasmic serine hydroxymethyltransferase 
DHFR: Dihydrofolate reductase 
DMG: Dimethylglycine 
DMGDH: Dimethylglyine dehydrogenase 
DLHP: Dorsolateral hingepoint 
dTMP: Thymidylate 
dUMP: Deoxyuridylate  
FDR: False discovery rate 
FPGS: Folylpolyglutamate synthetase 
GAR: Glycinamide ribonucleotide 
GCS-H: Glycine cleavage system H 
GLDC: Glycine decarboxylase 
H&E: Hematoxylin and eosin  






m/z: mass to charge ratio 
MEFs: Mouse embryonic fibroblasts 
MHP: Median hinge point 
MSCs: Mesenchymal stem cells 
MTHFD1: C1-THF-synthase 
MTHFR: Methylenetetrahydrofolate reductase 
MTFMT: Methionyl-tRNA formyltransferase  
NTC: Neural tube closure 
NTD: Neural tube defect 
PABA: Para-aminobenzoic acid 
PCFT: Proton-coupled folate transporter 
RFC: Reduced folate carrier 
SAM: S-adenosyl methionine  
SDH: Sarcosine dehydrogenase 
SHMT: Serine hydroxymethyltransferase 
SFXN1: Sideroflxin 1 
SNP: Single nucleotide polymorphism 
SUMO: Small ubiquitin-like modifier 
TCA: Tricarboxylic acid 
THF: Tetrahydrofolate 






Appendix II: A Protocol of Paraffin Embedding of Embryos E7-9.5 for 
Histological Analysis 
1. Dissect embyros in ice cold PBS, then transfer to small glass vial, and incubate in 
4% Paraformaldehyde in PBS overnight at 4º C. 
2. Wash fixed embryos twice with room temperature PBS. 
3. Incubate embryo in 70% EtOH for 5 minutes. 
4. Incubate embryo in 95% EtOH for 5 minutes.  
5. Incubate embryo in 100% EtOH for 5 minutes, twice. 
6. Incubate embryo in Xylene Substitute (Histo-Clear, National Diagnostics) for 5 
minutes, twice.  
7. Transfer the embryos into Peel-a-way disposable plastic embedding molds 
(Polysciences, Inc) containing melted paraffin at 60°C. 
8. Incubate embryo in paraffin for 5 minutes.  
9. Remove and replace the paraffin with fresh paraffin at 60°C. 
10. Incubate embryo at 60°C for 15 minutes.  
11. Repeat step 9. 
12. Incubate embryo at 60°C for 30 minutes.  
13. Orient embryo in the correct position within the embedding mold under a 
dissection microscope (Nikon Eclipse Compound Microscope). 
14. Allow paraffin to harden completely overnight, or incubate mold on ice for 1 hour 
to expedite processing. 
15. Peel off embedding mold, maintaining correct alignment and position of 






16. Prepare paraffin embedding cassette (Shandon Biopsy Processing/Embedding 
Casette, Thermo Fisher), alongside melted paraffin wax, a metal lab spatula, and a 
Bunsen burner. 
17. Pipette several drops of molten paraffin onto embedding cassette to create a base 
onto which the paraffin block will adhere onto the cassette. 
18. Heat metal spatula over Bunsen burner, and use to melt bottom of excised 
embryo-containing paraffin block.  
19. Quickly apply the embryo-containing paraffin block onto the cassette where the 
molten paraffin has been deposited, and mount the paraffin onto the cassette. 
20. Repeat step 14. 
21. Once completely hardened, section embryo at 7µm using a microtome (Leica 
Biosystems), and mount on negatively charged glass microscope slides. Proceed 
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